Hydroxychloroquine in systemic lupus erythematosus, anti-SSA/SSB, and antiphospholipid antibody-positive pregnancies
Pregnancies in patients with systemic lupus erythematosus (SLE) and those positive for anti-SSA/SSB or antiphospholipid antibodies carry a heightened risk of adverse pregnancy outcomes (APOs), including preeclampsia, preterm birth, and congenital heart block. Among available therapies, hydroxychloro...
Uloženo v:
| Vydáno v: | American journal of obstetrics and gynecology |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
United States
Elsevier Inc
08.09.2025
|
| Témata: | |
| ISSN: | 0002-9378, 1097-6868, 1097-6868 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Pregnancies in patients with systemic lupus erythematosus (SLE) and those positive for anti-SSA/SSB or antiphospholipid antibodies carry a heightened risk of adverse pregnancy outcomes (APOs), including preeclampsia, preterm birth, and congenital heart block. Among available therapies, hydroxychloroquine (HCQ) plays a pivotal role due to its immunomodulatory and antithrombotic properties, which may help improve pregnancy outcomes. Emerging evidence supports HCQ's role in reducing SLE flares, as well as lowering the recurrence risk of congenital heart block in anti-SSA/SSB–positive pregnancies. Additionally, in patients with antiphospholipid antibodies, HCQ may serve as an adjunctive therapy to mitigate obstetric complications, particularly in refractory cases. Despite early concerns about teratogenicity, large cohort studies and international guidelines affirm HCQ's safety at standard doses (≤400 mg/day), with no consistent association with congenital malformations (CMs). Recent research suggests that subtherapeutic HCQ blood levels during pregnancy may correlate with higher maternal disease activity and adverse pregnancy outcomes, though their primary utility currently lies in identifying nonadherence. Given the heightened risk of pregnancy complications in this population, a clear understanding of HCQ's essential role is crucial for both patients and their multidisciplinary care teams. This review provides up-to-date information on HCQ in pregnancy to help guide clinical decision-making.
[Display omitted] |
|---|---|
| AbstractList | Pregnancies in patients with systemic lupus erythematosus (SLE) and those positive for anti-SSA/SSB or antiphospholipid antibodies carry a heightened risk of adverse pregnancy outcomes (APOs), including preeclampsia, preterm birth, and congenital heart block. Among available therapies, hydroxychloroquine (HCQ) plays a pivotal role due to its immunomodulatory and antithrombotic properties, which may help improve pregnancy outcomes. Emerging evidence supports HCQ's role in reducing SLE flares, as well as lowering the recurrence risk of congenital heart block in anti-SSA/SSB–positive pregnancies. Additionally, in patients with antiphospholipid antibodies, HCQ may serve as an adjunctive therapy to mitigate obstetric complications, particularly in refractory cases. Despite early concerns about teratogenicity, large cohort studies and international guidelines affirm HCQ's safety at standard doses (≤400 mg/day), with no consistent association with congenital malformations (CMs). Recent research suggests that subtherapeutic HCQ blood levels during pregnancy may correlate with higher maternal disease activity and adverse pregnancy outcomes, though their primary utility currently lies in identifying nonadherence. Given the heightened risk of pregnancy complications in this population, a clear understanding of HCQ's essential role is crucial for both patients and their multidisciplinary care teams. This review provides up-to-date information on HCQ in pregnancy to help guide clinical decision-making.
[Display omitted] Pregnancies in patients with systemic lupus erythematosus (SLE) and those positive for anti-SSA/SSB or antiphospholipid antibodies carry a heightened risk of adverse pregnancy outcomes (APOs), including preeclampsia, preterm birth, and congenital heart block. Among available therapies, hydroxychloroquine (HCQ) plays a pivotal role due to its immunomodulatory and antithrombotic properties, which may help improve pregnancy outcomes. Emerging evidence supports HCQ's role in reducing SLE flares, as well as lowering the recurrence risk of congenital heart block in anti-SSA/SSB-positive pregnancies. Additionally, in patients with antiphospholipid antibodies, HCQ may serve as an adjunctive therapy to mitigate obstetric complications, particularly in refractory cases. Despite early concerns about teratogenicity, large cohort studies and international guidelines affirm HCQ's safety at standard doses (≤400 mg/day), with no consistent association with congenital malformations (CMs). Recent research suggests that subtherapeutic HCQ blood levels during pregnancy may correlate with higher maternal disease activity and adverse pregnancy outcomes, though their primary utility currently lies in identifying nonadherence. Given the heightened risk of pregnancy complications in this population, a clear understanding of HCQ's essential role is crucial for both patients and their multidisciplinary care teams. This review provides up-to-date information on HCQ in pregnancy to help guide clinical decision-making. Pregnancies in patients with systemic lupus erythematosus (SLE) and those positive for anti-SSA/SSB or antiphospholipid antibodies carry a heightened risk of adverse pregnancy outcomes (APOs), including preeclampsia, preterm birth, and congenital heart block. Among available therapies, hydroxychloroquine (HCQ) plays a pivotal role due to its immunomodulatory and antithrombotic properties, which may help improve pregnancy outcomes. Emerging evidence supports HCQ's role in reducing SLE flares, as well as lowering the recurrence risk of congenital heart block in anti-SSA/SSB-positive pregnancies. Additionally, in patients with antiphospholipid antibodies, HCQ may serve as an adjunctive therapy to mitigate obstetric complications, particularly in refractory cases. Despite early concerns about teratogenicity, large cohort studies and international guidelines affirm HCQ's safety at standard doses (≤400 mg/day), with no consistent association with congenital malformations. Recent research suggests that subtherapeutic HCQ blood levels during pregnancy may correlate with higher maternal disease activity and adverse pregnancy outcomes ,though their primary utility currently lies in identifying nonadherence. Given the heightened risk of pregnancy complications in this population, a clear understanding of HCQ's essential role is crucial for both patients and their multidisciplinary care teams. This review provides up-to-date information on HCQ in pregnancy to help guide clinical decision-making.Pregnancies in patients with systemic lupus erythematosus (SLE) and those positive for anti-SSA/SSB or antiphospholipid antibodies carry a heightened risk of adverse pregnancy outcomes (APOs), including preeclampsia, preterm birth, and congenital heart block. Among available therapies, hydroxychloroquine (HCQ) plays a pivotal role due to its immunomodulatory and antithrombotic properties, which may help improve pregnancy outcomes. Emerging evidence supports HCQ's role in reducing SLE flares, as well as lowering the recurrence risk of congenital heart block in anti-SSA/SSB-positive pregnancies. Additionally, in patients with antiphospholipid antibodies, HCQ may serve as an adjunctive therapy to mitigate obstetric complications, particularly in refractory cases. Despite early concerns about teratogenicity, large cohort studies and international guidelines affirm HCQ's safety at standard doses (≤400 mg/day), with no consistent association with congenital malformations. Recent research suggests that subtherapeutic HCQ blood levels during pregnancy may correlate with higher maternal disease activity and adverse pregnancy outcomes ,though their primary utility currently lies in identifying nonadherence. Given the heightened risk of pregnancy complications in this population, a clear understanding of HCQ's essential role is crucial for both patients and their multidisciplinary care teams. This review provides up-to-date information on HCQ in pregnancy to help guide clinical decision-making. |
| Author | Marder, Wendy Somers, Emily C. Romero, Vivian C. Saleh, Zeinab F. |
| Author_xml | – sequence: 1 givenname: Zeinab F. orcidid: 0009-0001-9474-8516 surname: Saleh fullname: Saleh, Zeinab F. email: salehz@med.umich.edu organization: Department of Internal Medicine-Rheumatology, University of Michigan, Ann Arbor, MI – sequence: 2 givenname: Emily C. surname: Somers fullname: Somers, Emily C. email: emsomers@umich.edu organization: Departments of Internal Medicine-Rheumatology, Environmental Health, and Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI – sequence: 3 givenname: Vivian C. surname: Romero fullname: Romero, Vivian C. email: Vivian.Romero@corewellhealth.org organization: Department of Obstetrics, Gynecology and Reproductive Biology, College of Human Medicine, Michigan State University, Grand Rapids, MI – sequence: 4 givenname: Wendy surname: Marder fullname: Marder, Wendy email: wmarder@med.umich.edu organization: Departments of Internal Medicine-Rheumatology and Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40930382$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFUU1v1TAQtFARfS38AQ4oRw4kXdv5RKhSWwFFqtRD4Gw5zqbPIbGDnVTk39fhFQ5I0INl7WhmVzNzQo6MNUjIawoJBZqf9Yns7V3CgGUJVAkAe0Z2FKoizsu8PCI7CFBc8aI8Jife99vIKvaCHKdQceAl25H5em2d_bmq_WCd_bFog5E2kV_9jKNW0bBMi4_QrfMeRzlbv_h3kTSzjuv64qyuL7ep_YVMe-vDG_SkD0Bj2zWerNezvsdocnhnpFEa_UvyvJODx1eP_yn59unj16vr-Ob285eri5tYcQ5zXGVFyzLMsw54oxSVbcMktJQiU6riTYGSQsFo1lWcgmxkSllTNIGWdph2kp-St4e902YN_SxG7RUOgzRoFy84S8u8KLM8D9Q3j9SlGbEVk9OjdKv4nVQgsANBOeu9w-4PhYLY6hC92OoQWx0CKhHCDqIPBxEGl_canfDBv1HYaodqFq3V_5ef_yVXgzZayeE7ruh7uzgT8hNUeCZA1FvBW90sA8gzvi14_-8FT11_ACPkviA |
| Cites_doi | 10.1016/j.reprotox.2013.04.005 10.1161/CIRCULATIONAHA.111.089268 10.1016/j.reprotox.2019.05.056 10.1093/rheumatology/41.8.924 10.1007/s10067-016-3270-5 10.1136/annrheumdis-2016-210012 10.1002/art.22159 10.1002/art.27289 10.1177/0961203315591027 10.3109/03009742.2011.626442 10.1002/acr.24130 10.1016/j.preghy.2022.11.006 10.1038/s41584-020-0372-x 10.1080/25785826.2020.1868652 10.1177/0961203314551812 10.1136/ard.55.7.486 10.1016/j.reuma.2019.04.002 10.1016/j.ajog.2022.09.001 10.1002/art.41621 10.1016/0049-3848(95)00028-3 10.1056/NEJM199707173370303 10.1136/lupus-2024-001239 10.4049/jimmunol.165.3.1534 10.1016/j.jbspin.2018.03.006 10.1016/S2665-9913(23)00215-1 10.1016/0049-3848(94)90270-4 10.1002/acr.25386 10.31486/toj.20.0013 10.1016/j.ajog.2015.08.003 10.1136/rmdopen-2018-000785 10.1002/art.11304 10.1055/s-0037-1613033 10.1016/j.bbrc.2025.151994 10.55563/clinexprheumatol/styx9u 10.1016/j.intimp.2023.111269 10.1111/jog.14561 10.1093/rheumatology/keac551 10.1016/j.autrev.2007.11.011 10.1136/ard.2009.119263 10.1007/s00296-003-0309-0 10.1016/j.ajog.2015.09.078 10.1001/jama.1960.03020150054010 10.1002/acr.25422 10.1177/0961203310361485 10.1542/peds.108.3.776 10.1182/blood.V95.11.3460 10.1002/art.38262 10.1074/jbc.M111.263657 10.1016/S0022-3565(25)26585-5 10.1080/15563650.2020.1817479 10.1097/CRD.0000000000000026 10.1002/acr.25279 10.1136/ard.32.6.547 10.1016/j.ajog.2012.09.020 10.1055/s-0039-3402752 10.1136/ard.2008.093013 10.1053/j.gastro.2020.05.001 10.1016/j.thromres.2021.08.004 10.1093/rheumatology/kex191 10.1002/art.24232 10.1097/AOG.0000000000003176 10.1136/lupus-2022-000841 10.1136/lupus-2021-000651 10.3389/fphar.2021.722511 10.1177/09612033221074192 10.1007/s10067-022-06496-2 10.3899/jrheum.180158 10.1146/annurev-pharmtox-011613-140009 10.1136/annrheumdis-2016-209770 10.1016/j.ajog.2020.09.007 10.1177/10600280221113572 10.1093/rheumatology/keu095.004 10.1055/s-0040-1715140 10.1093/rheumatology/39.9.1014 10.1007/s00228-019-02723-z 10.1016/j.jacc.2020.05.045 10.1097/01.AOG.0000423816.39542.0f 10.3109/03009746209165073 10.1002/art.42015 10.3390/jcm11030675 10.6061/clinics/2013(06)07 10.1177/0961203314555352 10.3390/ijms20040892 10.7326/M19-0120 10.1093/rheumatology/keac372 10.1016/j.ajog.2011.06.064 10.1016/j.rpth.2024.102665 10.4103/0366-6999.207471 10.1055/s-0037-1603359 10.1093/rheumatology/35.2.133 10.1016/0192-0561(87)90027-0 10.1191/096120301678646137 10.1177/0961203306071872 10.1177/09612033211007199 10.1016/S1472-6483(10)62013-5 10.1007/s40262-018-0712-z 10.1093/rheumatology/keaa592 10.1007/s12026-016-8888-5 10.1371/journal.pone.0271560 10.1097/HJH.0000000000003279 10.1007/s10067-019-04556-8 10.1002/bdr2.1943 10.1007/s00404-020-05762-5 10.1177/0961203310378669 10.1016/0002-9343(83)91266-4 10.1136/annrheumdis-2012-eular.3169 10.1177/0961203312437270 10.1182/blood-2008-03-144204 10.1160/th15-06-0491 10.1136/lupus-2021-000602 10.1093/rheumatology/keae168 10.1155/2017/2810202 10.1016/S2665-9913(25)00076-1 10.1016/j.autrev.2015.01.012 10.1007/s12026-016-8812-z 10.1002/art.22157 10.1177/09612033211066455 10.1016/j.ophtha.2016.01.058 10.1007/s40744-020-00273-w 10.1136/annrheumdis-2017-211641 10.1007/s11427-020-1732-2 10.1111/jth.12570 10.1007/s00296-019-04372-y 10.1002/ajh.25862 10.1016/j.ard.2025.02.023 10.1177/0961203393002001031 10.1016/j.placenta.2025.06.013 10.7326/M14-2235 10.1002/art.42793 10.1002/art.1780301219 10.3390/jcm12020485 10.1016/j.rdc.2007.02.005 10.1002/art.10150 10.1177/0961203319843343 10.1016/j.autrev.2018.05.012 10.3899/jrheum.120157 |
| ContentType | Journal Article |
| Copyright | 2025 The Author(s) The Author(s) Copyright © 2025 The Author(s). Published by Elsevier Inc. All rights reserved. |
| Copyright_xml | – notice: 2025 The Author(s) – notice: The Author(s) – notice: Copyright © 2025 The Author(s). Published by Elsevier Inc. All rights reserved. |
| DBID | 6I. AAFTH AAYXX CITATION NPM 7X8 |
| DOI | 10.1016/j.ajog.2025.09.002 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1097-6868 |
| ExternalDocumentID | 40930382 10_1016_j_ajog_2025_09_002 S0002937825006532 1_s2_0_S0002937825006532 |
| Genre | Journal Article Review |
| GroupedDBID | --- --K --M -ET .1- .55 .FO .GJ .XZ .~1 0R~ 1B1 1CY 1P~ 1~. 1~5 23M 2KS 354 3O- 4.4 457 4CK 4G. 53G 5GY 5RE 5VS 6J9 7-5 85S 8F7 8P~ AAEDT AAEDW AAIKC AAIKJ AAKOC AALRI AAMNW AAOAW AAQFI AAQQT AAQXK AATTM AAWTL AAXKI AAXUO AAYJJ AAYWO ABBQC ABCQX ABDPE ABFNM ABFRF ABJNI ABMAC ABMZM ABOCM ABPMR ABWVN ABXDB ACDAQ ACGFO ACGFS ACIEU ACLOT ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO ADVLN AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEVXI AFCHL AFFNX AFJKZ AFPUW AFRHN AFTJW AFXIZ AGHFR AGNAY AGQPQ AGUBO AGYEJ AHDLI AI. AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV C45 C5W CAG COF CS3 EBS EFJIC EFKBS EFLBG EJD EO8 EX3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-Q GBLVA HVGLF HZ~ IH2 IHE J1W K-O KOM LPU M41 MO0 N4W N9A NEJ NQ- O-L O9- OAUVE OBH OCB OGEVE OHH OHT OMK OQ. OVD P-8 P-9 P2P PC. PH~ Q38 R2- ROL RPZ RXW SDF SEL SES SEW SJN SPCBC SSH SSZ T5K TAE TEORI TWZ UDS UGJ UHB UHS UHU UKR UNMZH UV1 VH1 VVN WH7 WOQ WOW X6Y X7M XFW YFH YOC YYQ YZZ Z5R ZGI ZXP ZY1 ~G- ~H1 ~HD 6I. AAFTH AAYXX CITATION XRW NPM 7X8 |
| ID | FETCH-LOGICAL-c330t-957d25e65f03bcc1adb2a0d11e2cc93b7ea107215f9310aba412b7badb4fe4fa3 |
| ISSN | 0002-9378 1097-6868 |
| IngestDate | Thu Oct 02 21:28:48 EDT 2025 Fri Oct 03 01:51:53 EDT 2025 Sat Nov 29 07:19:06 EST 2025 Sat Nov 01 16:59:35 EDT 2025 Sat Oct 25 09:10:12 EDT 2025 Sat Nov 01 15:01:26 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | antiphospholipid syndrome systemic lupus erythematosus adverse pregnancy outcomes hydroxychloroquine autoimmune rheumatic diseases congenital malformations teratogenicity SSA/SSB positive |
| Language | English |
| License | This is an open access article under the CC BY-NC-ND license. Copyright © 2025 The Author(s). Published by Elsevier Inc. All rights reserved. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c330t-957d25e65f03bcc1adb2a0d11e2cc93b7ea107215f9310aba412b7badb4fe4fa3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| ORCID | 0009-0001-9474-8516 |
| OpenAccessLink | https://dx.doi.org/10.1016/j.ajog.2025.09.002 |
| PMID | 40930382 |
| PQID | 3248678566 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_3248678566 pubmed_primary_40930382 crossref_primary_10_1016_j_ajog_2025_09_002 elsevier_sciencedirect_doi_10_1016_j_ajog_2025_09_002 elsevier_clinicalkeyesjournals_1_s2_0_S0002937825006532 elsevier_clinicalkey_doi_10_1016_j_ajog_2025_09_002 |
| PublicationCentury | 2000 |
| PublicationDate | 2025-Sep-08 |
| PublicationDateYYYYMMDD | 2025-09-08 |
| PublicationDate_xml | – month: 09 year: 2025 text: 2025-Sep-08 day: 08 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | American journal of obstetrics and gynecology |
| PublicationTitleAlternate | Am J Obstet Gynecol |
| PublicationYear | 2025 |
| Publisher | Elsevier Inc |
| Publisher_xml | – name: Elsevier Inc |
| References | Müller-Calleja, Manukyan, Canisius (bib19) 2017; 76 Barros Edington, de Rezende, Dos Santos (bib28) 2022; 31 Russell, Dey, Flint (bib51) 2023; 62 Wu, Guller, Rand (bib122) 2011; 205 Levy, Vilela, Cataldo (bib68) 2001; 10 Kothari, Digole, Kamat (bib6) 2016; 64 Weber, Levitz (bib14) 2000; 165 Jancinová, Nosál, Petríková (bib34) 1994; 74 Garg, Astor, Saric (bib134) 2024; 76 Fasano, Messiniti, Iudici (bib136) 2023; 10 Gabourel (bib48) 1963; 141 Cooper, Cheetham, Li (bib63) 2014; 66 (bib133) 2012; 120 (bib54) 2019; 133 Sciascia, Hunt, Talavera-Garcia (bib126) 2016; 214 Willis, Seif, McGwin (bib15) 2012; 21 Simopoulou, Sfakianoudis, Maziotis (bib116) 2019; 20 Martínez-Sánchez, Pérez-Pinto, Robles-Marhuenda (bib108) 2017; 65 Yu, Li, Chen (bib16) 2020; 63 Neill, Panayi, Duthie (bib49) 1973; 32 Viktil, Engeland, Furu (bib65) 2012; 41 Abd Rahman, Min Tun, Kamisan Atan (bib95) 2020; 42 Broder, Putterman (bib39) 2013; 40 Simard, Liu, Rector (bib90) 2024; 76 Do, Rizk, Druzin (bib96) 2020; 37 Cecchi, Ferraris (bib32) 1962; 8 Jung, Bobba, Su (bib26) 2010; 62 Izmirly, Kim, Friedman (bib111) 2020; 76 Costedoat-Chalumeau, Amoura, Aymard (bib47) 2002; 46 Gayed, Khamashta, Culliford (bib143) 2014; 53 Cardiel, Carrillo, Pérez (bib147) 2021; 17 Georgiou, Politi, Katsimbri (bib5) 2000; 39 Arachchillage, Mobayen, Laffan (bib41) 2025; 9 Rand, Wu, Quinn (bib38) 2008; 112 Sciascia, Branch, Levy (bib123) 2016; 115 Talarico, Chakravarty, Liu (bib76) 2023; 57 Howren, Rebić, Sayre (bib60) 2020; 38 Diav-Citrin, Blyakhman, Shechtman (bib64) 2013; 39 Ke, Rostami-Hodjegan, Zhao (bib137) 2014; 54 Kaiser, Cleveland, Criswell (bib29) 2009; 68 Doyno, Sobieraj, Baker (bib75) 2021; 59 Belizna, Pregnolato, Abad (bib130) 2018; 17 Tedeschi, Guan, Fine (bib4) 2016; 35 Balevic, Weiner, Clowse (bib141) 2022; 9 Huybrechts, Bateman, Zhu (bib59) 2021; 224 El Hasbani, Viola, Sciascia (bib115) 2021; 8 Ruiz-Irastorza, Lima, Alves (bib80) 1996; 35 Fredi, Argolini, Angeli (bib113) 2023; 41 Rand, Wu, Andree (bib118) 1997; 337 Alijotas-Reig, Esteve-Valverde, Anunciación-Llunell (bib119) 2022; 11 Fox, Kang (bib11) 1993; 2 Clowse, Eudy, Balevic (bib7) 2022; 9 Sung, Choi, Roh (bib43) 2025; 168 Saxena, Izmirly, Mendez (bib104) 2014; 22 Skorpen, Lydersen, Gilboe (bib3) 2018; 77 Liu, Zhang, Wei (bib88) 2021; 303 Ye, Gu, Tao (bib127) 2017; 130 Izmirly, Kim, Llanos (bib106) 2010; 69 Ruiz-Irastorza, Egurbide, Pijoan (bib23) 2006; 15 Zhu, Wang, Sun (bib85) 2024; 11 Buchanan, Toubi, Khamashta (bib69) 1996; 55 Espinola, Pierangeli, Gharavi (bib37) 2002; 87 Goldman, Gilman, Hollenback (bib20) 2000; 95 Reynolds, Gayed, Khamashta (bib56) 2023; 62 Tektonidou, Laskari, Panagiotakos (bib25) 2009; 61 Ernst, Rose, Lee (bib33) 1984; 4 Kuipers, van Zwieten, Heijmans (bib79) 2020; 95 Koh, Ko, Kwok (bib99) 2015; 24 Liu, Wei, Zhang (bib86) 2023; 42 Balevic, Cohen-Wolkowiez, Eudy (bib138) 2019; 46 Seo, Chae, Kim (bib97) 2019; 28 Andreoli, Bertsias, Agmon-Levin (bib82) 2017; 76 Gisondi, Piaserico, Bordin (bib74) 2021; 39 Al Arfaj, Khalil (bib100) 2010; 19 Chen, Gelber, Witter (bib101) 2015; 24 Mekinian, Vicaut, Cohen (bib131) 2018; 46 Choi, Hwang, Sung (bib45) 2022; 40 Schrezenmeier, Dörner (bib8) 2020; 16 Scott, Greenwood, Hayes (bib46) 2019; 87 Silva, Mariz, Rocha (bib17) 2013; 68 Balevic, Green, Clowse (bib140) 2019; 58 Chambers, Johnson, Xu (bib57) 2022; 74 Leroux, Desveaux, Parcevaux (bib62) 2015; 24 Pan, Jin, Dai (bib135) 2024; 126 Guillotin, Bouhet, Barnetche (bib89) 2018; 85 Barsalou, Jaeggi, Laskin (bib109) 2017; 56 Simard, Liu, Chakravarty (bib1) 2024; 76 Peng, Liu, Zhang (bib144) 2019; 75 Gerde, Ibarra, Mac Kenzie (bib129) 2021; 206 Alle, Guettrot-Imbert, Larosa (bib142) 2024 Beksac, Donmez (bib98) 2021; 47 Wallace (bib24) 1987; 30 Balevic (bib139) 2019 Mekinian, Lazzaroni, Kuzenko (bib125) 2015; 14 Silver, Craigo, Porter (bib53) 2023; 228 Bertrand, Cloitre, Ticolat (bib35) 1990; 50 Bérard, Sheehy, Zhao (bib71) 2021; 12 Izmirly, Rivera, Buyon (bib102) 2007; 33 Law, Magder, Fang, Petri (bib21) 2012; 71 Stern, Chamley (bib117) 2006; 13 Redman, Staff (bib18) 2015; 213 Mollerach, Scolnik, Catoggio (bib110) 2019; 38 MADOW (bib31) 1960; 172 Kadife, Hannan, Harper (bib42) 2022; 17 Buyon, Kim, Guerra (bib81) 2015; 163 Petri, Hellmann, Hochberg (bib22) 1994; 37 Limper, Scirè, Talarico (bib124) 2018; 4 Bygbjerg, Svenson, Theander (bib10) 1987; 9 Richter, Becker, Ostendorf (bib78) 2003; 23 Rüegg, Pluma, Hamroun (bib52) 2025; 84 Marchetti, Ruffatti, Wuillemin (bib121) 2014; 12 Phillips, Nathan, Graham (bib92) 2023; 31 Andersson, Skov, Andersen (bib70) 2021; 60 van den Borne, Dijkmans, de Rooij (bib13) 1997; 24 Anuwutnavin, Chuenchitkultavorn, Nitiyarom (bib112) 2022; 31 Schreiber, Breen, Cohen (bib132) 2017; 43 Erkan, Yazici, Peterson (bib27) 2002; 41 Nguyen, Sandström, Svenungsson (bib83) 2025 Ruffatti, Tonello, Hoxha (bib128) 2018; 118 Sammaritano, Bermas, Chakravarty (bib50) 2020; 72 Alvarez, Briassouli, Clancy (bib103) 2011; 286 Sultan, Altayar, Siddique (bib73) 2020; 159 Hu, Gao, Huang (bib91) 2023; 12 Rector, Marić, Chaichian (bib84) 2024; 76 Mehta, Luo, Xu (bib2) 2019; 171 Qi, Cai, Wang (bib44) 2025; 770 Schreiber, Giles, Costedoat-Chalumeau (bib72) 2023; 5 Tunks, Clowse, Miller (bib107) 2013; 208 Duan, Ma, Wen (bib87) 2021; 30 Liu, Zhang, Mei (bib145) 2016; 36 Nosál, Jancinová, Petríková (bib36) 1995; 77 Petri, Konig, Li (bib30) 2021; 73 Baalbaki, Szychowski, Tang (bib93) 2020; 20 Howley, Werler, Fisher (bib58) 2021; 113 (bib148) 2001; 108 Marmor, Kellner, Lai (bib77) 2016; 123 Kroese, de Hair, Limper (bib61) 2017; 2017 Rand, Wu, Quinn (bib120) 2010; 19 Clowse, Magder, Witter (bib66) 2006; 54 Izmirly, Costedoat-Chalumeau, Pisoni (bib105) 2012; 126 Nuri, Taraborelli, Andreoli (bib40) 2017; 65 Canti, Scarrone, De Lorenzo (bib94) 2021; 44 Alhajeri, Abutiban, Al-Adsani (bib146) 2019; 39 Lafyatis, York, Marshak-Rothstein (bib9) 2006; 54 Salmeron, Lipsky (bib12) 1983; 75 Costedoat-Chalumeau, Amoura, Duhaut (bib67) 2003; 48 Nguyen, Svenungsson, Dominicus (bib55) 2025; 64 Cervera (bib114) 2008; 7 Müller-Calleja (10.1016/j.ajog.2025.09.002_bib19) 2017; 76 MADOW (10.1016/j.ajog.2025.09.002_bib31) 1960; 172 Huybrechts (10.1016/j.ajog.2025.09.002_bib59) 2021; 224 Barros Edington (10.1016/j.ajog.2025.09.002_bib28) 2022; 31 Limper (10.1016/j.ajog.2025.09.002_bib124) 2018; 4 Al Arfaj (10.1016/j.ajog.2025.09.002_bib100) 2010; 19 Belizna (10.1016/j.ajog.2025.09.002_bib130) 2018; 17 Cardiel (10.1016/j.ajog.2025.09.002_bib147) 2021; 17 Koh (10.1016/j.ajog.2025.09.002_bib99) 2015; 24 (10.1016/j.ajog.2025.09.002_bib133) 2012; 120 Anuwutnavin (10.1016/j.ajog.2025.09.002_bib112) 2022; 31 Simard (10.1016/j.ajog.2025.09.002_bib90) 2024; 76 Chen (10.1016/j.ajog.2025.09.002_bib101) 2015; 24 Martínez-Sánchez (10.1016/j.ajog.2025.09.002_bib108) 2017; 65 Duan (10.1016/j.ajog.2025.09.002_bib87) 2021; 30 Marchetti (10.1016/j.ajog.2025.09.002_bib121) 2014; 12 Rand (10.1016/j.ajog.2025.09.002_bib120) 2010; 19 Tektonidou (10.1016/j.ajog.2025.09.002_bib25) 2009; 61 Rand (10.1016/j.ajog.2025.09.002_bib38) 2008; 112 Gabourel (10.1016/j.ajog.2025.09.002_bib48) 1963; 141 Petri (10.1016/j.ajog.2025.09.002_bib22) 1994; 37 (10.1016/j.ajog.2025.09.002_bib148) 2001; 108 Yu (10.1016/j.ajog.2025.09.002_bib16) 2020; 63 Balevic (10.1016/j.ajog.2025.09.002_bib138) 2019; 46 Wallace (10.1016/j.ajog.2025.09.002_bib24) 1987; 30 Leroux (10.1016/j.ajog.2025.09.002_bib62) 2015; 24 Kadife (10.1016/j.ajog.2025.09.002_bib42) 2022; 17 Nosál (10.1016/j.ajog.2025.09.002_bib36) 1995; 77 Cooper (10.1016/j.ajog.2025.09.002_bib63) 2014; 66 Andersson (10.1016/j.ajog.2025.09.002_bib70) 2021; 60 Ye (10.1016/j.ajog.2025.09.002_bib127) 2017; 130 Kaiser (10.1016/j.ajog.2025.09.002_bib29) 2009; 68 Doyno (10.1016/j.ajog.2025.09.002_bib75) 2021; 59 El Hasbani (10.1016/j.ajog.2025.09.002_bib115) 2021; 8 Zhu (10.1016/j.ajog.2025.09.002_bib85) 2024; 11 Balevic (10.1016/j.ajog.2025.09.002_bib140) 2019; 58 Alhajeri (10.1016/j.ajog.2025.09.002_bib146) 2019; 39 Russell (10.1016/j.ajog.2025.09.002_bib51) 2023; 62 Stern (10.1016/j.ajog.2025.09.002_bib117) 2006; 13 Kothari (10.1016/j.ajog.2025.09.002_bib6) 2016; 64 Gayed (10.1016/j.ajog.2025.09.002_bib143) 2014; 53 Silver (10.1016/j.ajog.2025.09.002_bib53) 2023; 228 Howley (10.1016/j.ajog.2025.09.002_bib58) 2021; 113 Neill (10.1016/j.ajog.2025.09.002_bib49) 1973; 32 Rector (10.1016/j.ajog.2025.09.002_bib84) 2024; 76 Kuipers (10.1016/j.ajog.2025.09.002_bib79) 2020; 95 Bérard (10.1016/j.ajog.2025.09.002_bib71) 2021; 12 Izmirly (10.1016/j.ajog.2025.09.002_bib105) 2012; 126 Sung (10.1016/j.ajog.2025.09.002_bib43) 2025; 168 Viktil (10.1016/j.ajog.2025.09.002_bib65) 2012; 41 Diav-Citrin (10.1016/j.ajog.2025.09.002_bib64) 2013; 39 Ruiz-Irastorza (10.1016/j.ajog.2025.09.002_bib23) 2006; 15 Clowse (10.1016/j.ajog.2025.09.002_bib7) 2022; 9 Choi (10.1016/j.ajog.2025.09.002_bib45) 2022; 40 Ruffatti (10.1016/j.ajog.2025.09.002_bib128) 2018; 118 Jancinová (10.1016/j.ajog.2025.09.002_bib34) 1994; 74 Ernst (10.1016/j.ajog.2025.09.002_bib33) 1984; 4 Lafyatis (10.1016/j.ajog.2025.09.002_bib9) 2006; 54 Nguyen (10.1016/j.ajog.2025.09.002_bib55) 2025; 64 Goldman (10.1016/j.ajog.2025.09.002_bib20) 2000; 95 Guillotin (10.1016/j.ajog.2025.09.002_bib89) 2018; 85 Mehta (10.1016/j.ajog.2025.09.002_bib2) 2019; 171 Jung (10.1016/j.ajog.2025.09.002_bib26) 2010; 62 Abd Rahman (10.1016/j.ajog.2025.09.002_bib95) 2020; 42 Seo (10.1016/j.ajog.2025.09.002_bib97) 2019; 28 Balevic (10.1016/j.ajog.2025.09.002_bib141) 2022; 9 Costedoat-Chalumeau (10.1016/j.ajog.2025.09.002_bib47) 2002; 46 Ruiz-Irastorza (10.1016/j.ajog.2025.09.002_bib80) 1996; 35 Silva (10.1016/j.ajog.2025.09.002_bib17) 2013; 68 Simard (10.1016/j.ajog.2025.09.002_bib1) 2024; 76 Reynolds (10.1016/j.ajog.2025.09.002_bib56) 2023; 62 Phillips (10.1016/j.ajog.2025.09.002_bib92) 2023; 31 Law (10.1016/j.ajog.2025.09.002_bib21) 2012; 71 Willis (10.1016/j.ajog.2025.09.002_bib15) 2012; 21 Chambers (10.1016/j.ajog.2025.09.002_bib57) 2022; 74 Qi (10.1016/j.ajog.2025.09.002_bib44) 2025; 770 Fasano (10.1016/j.ajog.2025.09.002_bib136) 2023; 10 Rüegg (10.1016/j.ajog.2025.09.002_bib52) 2025; 84 Canti (10.1016/j.ajog.2025.09.002_bib94) 2021; 44 Izmirly (10.1016/j.ajog.2025.09.002_bib102) 2007; 33 Simopoulou (10.1016/j.ajog.2025.09.002_bib116) 2019; 20 Fox (10.1016/j.ajog.2025.09.002_bib11) 1993; 2 Andreoli (10.1016/j.ajog.2025.09.002_bib82) 2017; 76 Liu (10.1016/j.ajog.2025.09.002_bib145) 2016; 36 Gisondi (10.1016/j.ajog.2025.09.002_bib74) 2021; 39 Peng (10.1016/j.ajog.2025.09.002_bib144) 2019; 75 Marmor (10.1016/j.ajog.2025.09.002_bib77) 2016; 123 Baalbaki (10.1016/j.ajog.2025.09.002_bib93) 2020; 20 Bygbjerg (10.1016/j.ajog.2025.09.002_bib10) 1987; 9 Do (10.1016/j.ajog.2025.09.002_bib96) 2020; 37 Espinola (10.1016/j.ajog.2025.09.002_bib37) 2002; 87 Sciascia (10.1016/j.ajog.2025.09.002_bib123) 2016; 115 Costedoat-Chalumeau (10.1016/j.ajog.2025.09.002_bib67) 2003; 48 Buchanan (10.1016/j.ajog.2025.09.002_bib69) 1996; 55 Mollerach (10.1016/j.ajog.2025.09.002_bib110) 2019; 38 Levy (10.1016/j.ajog.2025.09.002_bib68) 2001; 10 Liu (10.1016/j.ajog.2025.09.002_bib88) 2021; 303 Scott (10.1016/j.ajog.2025.09.002_bib46) 2019; 87 Schreiber (10.1016/j.ajog.2025.09.002_bib72) 2023; 5 Izmirly (10.1016/j.ajog.2025.09.002_bib111) 2020; 76 Talarico (10.1016/j.ajog.2025.09.002_bib76) 2023; 57 Alvarez (10.1016/j.ajog.2025.09.002_bib103) 2011; 286 Wu (10.1016/j.ajog.2025.09.002_bib122) 2011; 205 Mekinian (10.1016/j.ajog.2025.09.002_bib125) 2015; 14 Clowse (10.1016/j.ajog.2025.09.002_bib66) 2006; 54 Saxena (10.1016/j.ajog.2025.09.002_bib104) 2014; 22 Tunks (10.1016/j.ajog.2025.09.002_bib107) 2013; 208 Petri (10.1016/j.ajog.2025.09.002_bib30) 2021; 73 Arachchillage (10.1016/j.ajog.2025.09.002_bib41) 2025; 9 Tedeschi (10.1016/j.ajog.2025.09.002_bib4) 2016; 35 Sammaritano (10.1016/j.ajog.2025.09.002_bib50) 2020; 72 Buyon (10.1016/j.ajog.2025.09.002_bib81) 2015; 163 Mekinian (10.1016/j.ajog.2025.09.002_bib131) 2018; 46 Alijotas-Reig (10.1016/j.ajog.2025.09.002_bib119) 2022; 11 van den Borne (10.1016/j.ajog.2025.09.002_bib13) 1997; 24 Izmirly (10.1016/j.ajog.2025.09.002_bib106) 2010; 69 Liu (10.1016/j.ajog.2025.09.002_bib86) 2023; 42 Salmeron (10.1016/j.ajog.2025.09.002_bib12) 1983; 75 Gerde (10.1016/j.ajog.2025.09.002_bib129) 2021; 206 Nguyen (10.1016/j.ajog.2025.09.002_bib83) 2025 Sciascia (10.1016/j.ajog.2025.09.002_bib126) 2016; 214 Rand (10.1016/j.ajog.2025.09.002_bib118) 1997; 337 Redman (10.1016/j.ajog.2025.09.002_bib18) 2015; 213 Broder (10.1016/j.ajog.2025.09.002_bib39) 2013; 40 Weber (10.1016/j.ajog.2025.09.002_bib14) 2000; 165 Howren (10.1016/j.ajog.2025.09.002_bib60) 2020; 38 Georgiou (10.1016/j.ajog.2025.09.002_bib5) 2000; 39 Bertrand (10.1016/j.ajog.2025.09.002_bib35) 1990; 50 Alle (10.1016/j.ajog.2025.09.002_bib142) 2024 Hu (10.1016/j.ajog.2025.09.002_bib91) 2023; 12 Beksac (10.1016/j.ajog.2025.09.002_bib98) 2021; 47 Nuri (10.1016/j.ajog.2025.09.002_bib40) 2017; 65 Richter (10.1016/j.ajog.2025.09.002_bib78) 2003; 23 Schrezenmeier (10.1016/j.ajog.2025.09.002_bib8) 2020; 16 Barsalou (10.1016/j.ajog.2025.09.002_bib109) 2017; 56 Schreiber (10.1016/j.ajog.2025.09.002_bib132) 2017; 43 Ke (10.1016/j.ajog.2025.09.002_bib137) 2014; 54 Fredi (10.1016/j.ajog.2025.09.002_bib113) 2023; 41 Cecchi (10.1016/j.ajog.2025.09.002_bib32) 1962; 8 Garg (10.1016/j.ajog.2025.09.002_bib134) 2024; 76 Balevic (10.1016/j.ajog.2025.09.002_bib139) 2019 Kroese (10.1016/j.ajog.2025.09.002_bib61) 2017; 2017 Pan (10.1016/j.ajog.2025.09.002_bib135) 2024; 126 Skorpen (10.1016/j.ajog.2025.09.002_bib3) 2018; 77 Sultan (10.1016/j.ajog.2025.09.002_bib73) 2020; 159 Erkan (10.1016/j.ajog.2025.09.002_bib27) 2002; 41 (10.1016/j.ajog.2025.09.002_bib54) 2019; 133 Cervera (10.1016/j.ajog.2025.09.002_bib114) 2008; 7 |
| References_xml | – volume: 163 start-page: 153 year: 2015 end-page: 163 ident: bib81 article-title: Predictors of pregnancy outcomes in patients with lupus: a cohort study publication-title: Ann Intern Med – volume: 214 start-page: 273.e1 year: 2016 end-page: 273.e8 ident: bib126 article-title: The impact of hydroxychloroquine treatment on pregnancy outcome in women with antiphospholipid antibodies publication-title: Am J Obstet Gynecol – volume: 171 start-page: 164 year: 2019 end-page: 171 ident: bib2 article-title: Trends in maternal and fetal outcomes among pregnant women with systemic lupus erythematosus in the United States: a cross-sectional analysis publication-title: Ann Intern Med – volume: 213 start-page: S9.e1 year: 2015 ident: bib18 article-title: Preeclampsia, biomarkers, syncytiotrophoblast stress, and placental capacity publication-title: Am J Obstet Gynecol – volume: 9 year: 2022 ident: bib141 article-title: Hydroxychloroquine PK and exposure-response in pregnancies with lupus: the importance of adherence for neonatal outcomes publication-title: Lupus Sci Med – volume: 126 year: 2024 ident: bib135 article-title: The presumable effects of hydroxychloroquine and its metabolites in the treatment of systemic lupus erythematosus publication-title: Int Immunopharmacol – volume: 84 start-page: 910 year: 2025 end-page: 926 ident: bib52 article-title: EULAR recommendations for use of antirheumatic drugs in reproduction, pregnancy, and lactation: 2024 update publication-title: Ann Rheum Dis – volume: 172 start-page: 1630 year: 1960 end-page: 1633 ident: bib31 article-title: Use of antimalarial drugs as "desludging" agents in vascular disease processes publication-title: J Am Med Assoc – volume: 62 start-page: e48 year: 2023 end-page: e88 ident: bib51 article-title: British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids publication-title: Rheumatology (Oxford) – volume: 14 start-page: 498 year: 2015 end-page: 502 ident: bib125 article-title: The efficacy of hydroxychloroquine for obstetrical outcome in anti-phospholipid syndrome: data from a European multicenter retrospective study publication-title: Autoimmun Rev – volume: 58 start-page: 525 year: 2019 end-page: 533 ident: bib140 article-title: Pharmacokinetics of hydroxychloroquine in pregnancies with rheumatic diseases publication-title: Clin Pharmacokinet – volume: 11 start-page: 675 year: 2022 ident: bib119 article-title: Pathogenesis, diagnosis and management of obstetric antiphospholipid syndrome: a comprehensive review publication-title: J Clin Med – volume: 42 start-page: 705 year: 2020 end-page: 711 ident: bib95 article-title: New benefits of hydroxychloroquine in pregnant women with systemic lupus erythematosus: a retrospective study in a tertiary centre publication-title: Rev Bras Ginecol Obstet – volume: 12 year: 2021 ident: bib71 article-title: Chloroquine and hydroxychloroquine use during pregnancy and the risk of adverse pregnancy outcomes using real-world evidence publication-title: Front Pharmacol – volume: 12 start-page: 910 year: 2014 end-page: 920 ident: bib121 article-title: Hydroxychloroquine restores trophoblast fusion affected by antiphospholipid antibodies publication-title: J Thromb Haemost – volume: 95 start-page: E194 year: 2020 end-page: E196 ident: bib79 article-title: Glucose-6-phosphate dehydrogenase deficiency-associated hemolysis and methemoglobinemia in a COVID-19 patient treated with chloroquine publication-title: Am J Hematol – volume: 76 start-page: 476 year: 2017 end-page: 485 ident: bib82 article-title: EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome publication-title: Ann Rheum Dis – volume: 4 year: 2018 ident: bib124 article-title: Antiphospholipid syndrome: state of the art on clinical practice guidelines publication-title: RMD Open – volume: 303 start-page: 435 year: 2021 end-page: 441 ident: bib88 article-title: Effect of hydroxychloroquine on preeclampsia in lupus pregnancies: a propensity score-matched analysis and meta-analysis publication-title: Arch Gynecol Obstet – volume: 113 start-page: 1245 year: 2021 end-page: 1256 ident: bib58 article-title: Maternal exposure to hydroxychloroquine and birth defects publication-title: Birth Defects Res – volume: 337 start-page: 154 year: 1997 end-page: 160 ident: bib118 article-title: Pregnancy loss in the antiphospholipid-antibody syndrome--a possible thrombogenic mechanism publication-title: N Engl J Med – volume: 39 start-page: 1014 year: 2000 end-page: 1019 ident: bib5 article-title: Outcome of lupus pregnancy: a controlled study publication-title: Rheumatology (Oxford) – volume: 9 start-page: 513 year: 1987 end-page: 519 ident: bib10 article-title: Effect of antimalarial drugs on stimulation and interleukin 2 production of human lymphocytes publication-title: Int J Immunopharmacol – volume: 68 start-page: 238 year: 2009 end-page: 241 ident: bib29 article-title: Risk and protective factors for thrombosis in systemic lupus erythematosus: results from a large, multi-ethnic cohort publication-title: Ann Rheum Dis – volume: 74 start-page: 495 year: 1994 end-page: 504 ident: bib34 article-title: On the inhibitory effect of chloroquine on blood platelet aggregation publication-title: Thromb Res – volume: 64 start-page: 117 year: 2025 end-page: 125 ident: bib55 article-title: Hydroxychloroquine in lupus or rheumatoid arthritis pregnancy and risk of major congenital malformations: a population-based cohort study publication-title: Rheumatology (Oxford) – volume: 61 start-page: 29 year: 2009 end-page: 36 ident: bib25 article-title: Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies publication-title: Arthritis Rheum – volume: 85 start-page: 663 year: 2018 end-page: 668 ident: bib89 article-title: Hydroxychloroquine for the prevention of fetal growth restriction and prematurity in lupus pregnancy: a systematic review and meta-analysis publication-title: Joint Bone Spine – volume: 44 start-page: 204 year: 2021 end-page: 210 ident: bib94 article-title: Low incidence of intrauterine growth restriction in pregnant patients with systemic lupus erythematosus taking hydroxychloroquine publication-title: Immunol Med – volume: 73 start-page: 997 year: 2021 end-page: 1004 ident: bib30 article-title: Association of higher hydroxychloroquine blood levels with reduced thrombosis risk in systemic lupus erythematosus publication-title: Arthritis Rheumatol – volume: 112 start-page: 1687 year: 2008 end-page: 1695 ident: bib38 article-title: Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-beta2-glycoprotein I complexes to phospholipid bilayers publication-title: Blood – volume: 40 start-page: 2459 year: 2022 end-page: 2468 ident: bib45 article-title: Hydroxychloroquine reduces hypertension and soluble fms-like kinase-1 in a Nω-nitro-l-arginine methyl ester-induced preeclampsia rat model publication-title: J Hypertens – volume: 159 start-page: 320 year: 2020 end-page: 334.e27 ident: bib73 article-title: AGA institute rapid review of the gastrointestinal and liver manifestations of COVID-19, meta-analysis of international data, and recommendations for the consultative management of patients with COVID-19 publication-title: Gastroenterology – volume: 2017 year: 2017 ident: bib61 article-title: Hydroxychloroquine use in lupus patients during pregnancy is associated with longer pregnancy duration in preterm births publication-title: J Immunol Res – volume: 56 start-page: 1552 year: 2017 end-page: 1559 ident: bib109 article-title: Prenatal exposure to antimalarials decreases the risk of cardiac but not non-cardiac neonatal lupus: a single-centre cohort study publication-title: Rheumatology (Oxford) – volume: 46 start-page: 57 year: 2019 end-page: 63 ident: bib138 article-title: Hydroxychloroquine levels throughout pregnancies complicated by rheumatic disease: implications for maternal and neonatal outcomes publication-title: J Rheumatol – volume: 19 start-page: 460 year: 2010 end-page: 469 ident: bib120 article-title: The annexin A5-mediated pathogenic mechanism in the antiphospholipid syndrome: role in pregnancy losses and thrombosis publication-title: Lupus – volume: 770 year: 2025 ident: bib44 article-title: Hydroxychloroquine confers placental protection in antiphospholipid syndrome: mechanistic insights into autophagy regulation and trophoblast dysfunction publication-title: Biochem Biophys Res Commun – volume: 17 year: 2022 ident: bib42 article-title: Hydroxychloroquine reduces soluble Flt-1 secretion from human cytotrophoblast, but does not mitigate markers of endothelial dysfunction in vitro publication-title: PLoS One – volume: 8 start-page: 81 year: 2021 end-page: 94 ident: bib115 article-title: Antiphospholipid antibodies in inflammatory and autoimmune rheumatic and musculoskeletal diseases beyond lupus: a systematic review of the available evidence publication-title: Rheumatol Ther – volume: 63 start-page: 1515 year: 2020 end-page: 1521 ident: bib16 article-title: Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19 publication-title: Sci China Life Sci – volume: 24 start-page: 210 year: 2015 end-page: 217 ident: bib99 article-title: Hydroxychloroquine and pregnancy on lupus flares in Korean patients with systemic lupus erythematosus publication-title: Lupus – volume: 76 start-page: 526 year: 2024 end-page: 530 ident: bib1 article-title: Pregnancy outcomes in a diverse US lupus cohort publication-title: Arthritis Care Res (Hoboken) – volume: 12 start-page: 485 year: 2023 ident: bib91 article-title: Effect of hydroxychloroquine on lupus activity, preeclampsia and intrauterine growth restriction in pregnant women with systemic lupus erythematosus and/or antiphospholipid syndrome: a systematic review and meta-analysis publication-title: J Clin Med – volume: 41 start-page: 685 year: 2023 end-page: 693 ident: bib113 article-title: Anti-SSA/Ro positivity and congenital heart block: obstetric and foetal outcome in a cohort of anti-SSA/Ro positive pregnant patients with and without autoimmune diseases publication-title: Clin Exp Rheumatol – volume: 41 start-page: 924 year: 2002 end-page: 929 ident: bib27 article-title: A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome publication-title: Rheumatology (Oxford) – volume: 39 start-page: 1483 year: 2019 end-page: 1497 ident: bib146 article-title: Kuwait association of rheumatology 2018 treatment recommendations for patients with rheumatoid arthritis publication-title: Rheumatol Int – volume: 66 start-page: 444 year: 2014 end-page: 450 ident: bib63 article-title: Brief report: risk of adverse fetal outcomes associated with immunosuppressive medications for chronic immune-mediated diseases in pregnancy publication-title: Arthritis Rheumatol – volume: 123 start-page: 1386 year: 2016 end-page: 1394 ident: bib77 article-title: Recommendations on screening for chloroquine and hydroxychloroquine Retinopathy (2016 revision) publication-title: Ophthalmology – volume: 165 start-page: 1534 year: 2000 end-page: 1540 ident: bib14 article-title: Chloroquine interferes with lipopolysaccharide-induced TNF-alpha gene expression by a nonlysosomotropic mechanism publication-title: J Immunol – volume: 53 start-page: i55 year: 2014 ident: bib143 article-title: Longterm outcomes of children born to mothers with SLE exposed to hydroxychloroquine in pregnancy publication-title: Rheumatology – volume: 2 start-page: S9 year: 1993 end-page: S12 ident: bib11 article-title: Mechanism of action of antimalarial drugs: inhibition of antigen processing and presentation publication-title: Lupus – year: 2025 ident: bib83 article-title: Exposure to hydroxychloroquine in early pregnancy and incidence of pre-eclampsia and pre-term delivery in patients with systemic lupus erythematosus in Sweden: a nationwide population-based cohort study publication-title: Lancet Rheumatol – volume: 130 start-page: 1395 year: 2017 end-page: 1399 ident: bib127 article-title: Efficacy of different treatment regimens for antiphospholipid syndrome-related recurrent spontaneous abortion publication-title: Chin Med J (Engl) – volume: 69 start-page: 1827 year: 2010 end-page: 1830 ident: bib106 article-title: Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine publication-title: Ann Rheum Dis – volume: 71 start-page: 547 year: 2012 ident: bib21 article-title: SAT0222 hydroxychloroquine reduces thrombosis (both arterial and venous) in systemic lupus erythematosus, particularly in antiphospholipid positive patients publication-title: Ann Rheum Dis – volume: 62 start-page: 863 year: 2010 end-page: 868 ident: bib26 article-title: The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosus publication-title: Arthritis Rheum – volume: 50 start-page: 143 year: 1990 end-page: 146 ident: bib35 article-title: [Antiaggregation action of chloroquine] publication-title: Med Trop (Mars) – volume: 24 start-page: 147 year: 2015 end-page: 154 ident: bib101 article-title: Renal biopsy in the management of lupus nephritis during pregnancy publication-title: Lupus – volume: 43 start-page: 562 year: 2017 end-page: 571 ident: bib132 article-title: HYdroxychloroquine to improve pregnancy outcome in women with AnTIphospholipid antibodies (HYPATIA) protocol: a multinational randomized controlled trial of hydroxychloroquine versus placebo in addition to standard treatment in pregnant women with antiphospholipid syndrome or antibodies publication-title: Semin Thromb Hemost – volume: 118 start-page: 639 year: 2018 end-page: 646 ident: bib128 article-title: Effect of additional treatments combined with conventional therapies in pregnant patients with high-risk antiphospholipid syndrome: a multicentre study publication-title: Thromb Haemost – volume: 46 start-page: 1123 year: 2002 end-page: 1124 ident: bib47 article-title: Evidence of transplacental passage of hydroxychloroquine in humans publication-title: Arthritis Rheum – volume: 46 start-page: 598 year: 2018 end-page: 604 ident: bib131 article-title: [Hydroxychloroquine to obtain pregnancy without adverse obstetrical events in primary antiphospholipid syndrome: French phase II multicenter randomized trial, HYDROSAPL] publication-title: Gynecol Obstet Fertil Senol – volume: 133 start-page: e287 year: 2019 end-page: e295 ident: bib54 article-title: ACOG Committee Opinion No. 776: immune modulating therapies in pregnancy and lactation publication-title: Obstet Gynecol – volume: 31 start-page: 14 year: 2023 end-page: 16 ident: bib92 article-title: Preeclampsia in women with lupus - influence of aspirin and hydroxychloroquine on pregnancy outcome publication-title: Pregnancy Hypertens – volume: 65 start-page: 487 year: 2017 end-page: 494 ident: bib108 article-title: Obstetric and perinatal outcome in anti-Ro/SSA-positive pregnant women: a prospective cohort study publication-title: Immunol Res – volume: 42 start-page: 1223 year: 2023 end-page: 1235 ident: bib86 article-title: Hydroxychloroquine significantly decreases the risk of preeclampsia in pregnant women with autoimmune disorders: a systematic review and meta-analysis publication-title: Clin Rheumatol – volume: 95 start-page: 3460 year: 2000 end-page: 3466 ident: bib20 article-title: Hydroxychloroquine inhibits calcium signals in T cells: a new mechanism to explain its immunomodulatory properties publication-title: Blood – volume: 57 start-page: 463 year: 2023 end-page: 479 ident: bib76 article-title: Systematic review of psychiatric adverse effects induced by chloroquine and hydroxychloroquine: case reports and population studies publication-title: Ann Pharmacother – volume: 120 start-page: 1514 year: 2012 end-page: 1521 ident: bib133 article-title: Practice bulletin No. 132: antiphospholipid syndrome publication-title: Obstet Gynecol – volume: 31 start-page: 77 year: 2022 end-page: 88 ident: bib112 article-title: Prenatal predisposing factors associated with neonatal lupus erythematosus publication-title: Lupus – volume: 40 start-page: 30 year: 2013 end-page: 33 ident: bib39 article-title: Hydroxychloroquine use is associated with lower odds of persistently positive antiphospholipid antibodies and/or lupus anticoagulant in systemic lupus erythematosus publication-title: J Rheumatol – volume: 72 start-page: 461 year: 2020 end-page: 488 ident: bib50 article-title: 2020 American college of rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases publication-title: Arthritis Care Res (Hoboken) – volume: 108 start-page: 776 year: 2001 end-page: 789 ident: bib148 article-title: AoPCo. Transfer of drugs and other chemicals into human milk publication-title: Pediatrics – volume: 41 start-page: 196 year: 2012 end-page: 201 ident: bib65 article-title: Outcomes after anti-rheumatic drug use before and during pregnancy: a cohort study among 150,000 pregnant women and expectant fathers publication-title: Scand J Rheumatol – volume: 39 start-page: 1099 year: 2021 end-page: 1107 ident: bib74 article-title: The safety profile of hydroxychloroquine: major cutaneous and extracutaneous adverse events publication-title: Clin Exp Rheumatol – volume: 10 start-page: 401 year: 2001 end-page: 404 ident: bib68 article-title: Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study publication-title: Lupus – volume: 62 start-page: 1124 year: 2023 end-page: 1135 ident: bib56 article-title: Outcomes of children born to mothers with systemic lupus erythematosus exposed to hydroxychloroquine or azathioprine publication-title: Rheumatology (Oxford) – volume: 21 start-page: 830 year: 2012 end-page: 835 ident: bib15 article-title: Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA (LXXV), a multiethnic US cohort publication-title: Lupus – volume: 224 start-page: 290.e1 year: 2021 end-page: 290.e22 ident: bib59 article-title: Hydroxychloroquine early in pregnancy and risk of birth defects publication-title: Am J Obstet Gynecol – volume: 35 start-page: 133 year: 1996 end-page: 138 ident: bib80 article-title: Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies publication-title: Br J Rheumatol – volume: 36 start-page: E261 year: 2016 ident: bib145 publication-title: Excretion of hydroxychloroquine in milk of lactating patients. Pharmacotherapy – volume: 39 start-page: 58 year: 2013 end-page: 62 ident: bib64 article-title: Pregnancy outcome following in utero exposure to hydroxychloroquine: a prospective comparative observational study publication-title: Reprod Toxicol – volume: 228 start-page: B41 year: 2023 end-page: B60 ident: bib53 article-title: Society for maternal-fetal medicine consult series #64: systemic lupus erythematosus in pregnancy publication-title: Am J Obstet Gynecol – volume: 32 start-page: 547 year: 1973 end-page: 550 ident: bib49 article-title: Action of chloroquine phosphate in rheumatoid arthritis. II. Chromosome damaging effect publication-title: Ann Rheum Dis – volume: 37 start-page: 873 year: 2020 end-page: 880 ident: bib96 article-title: Does hydroxychloroquine protect against preeclampsia and preterm delivery in systemic lupus erythematosus pregnancies? publication-title: Am J Perinatol – volume: 31 start-page: 238 year: 2022 end-page: 245 ident: bib28 article-title: Efficacy of hydroxychloroquine in the prevention of thromboembolic events: a systematic review and meta-analysis publication-title: Lupus – volume: 9 year: 2022 ident: bib7 article-title: Hydroxychloroquine in the pregnancies of women with lupus: a meta-analysis of individual participant data publication-title: Lupus Sci Med – volume: 16 start-page: 155 year: 2020 end-page: 166 ident: bib8 article-title: Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology publication-title: Nat Rev Rheumatol – volume: 74 start-page: 711 year: 2022 end-page: 724 ident: bib57 article-title: Birth outcomes in women who have taken hydroxycholoroquine during pregnancy: a prospective cohort study publication-title: Arthritis Rheumatol – volume: 22 start-page: 263 year: 2014 end-page: 267 ident: bib104 article-title: Prevention and treatment in utero of autoimmune-associated congenital heart block publication-title: Cardiol Rev – volume: 17 start-page: 215 year: 2021 end-page: 228 ident: bib147 article-title: Update of the Mexican College of rheumatology guidelines for the pharmacological treatment of rheumatoid arthritis, 2018 publication-title: Reumatol Clin (Engl Ed) – volume: 20 start-page: 362 year: 2020 end-page: 367 ident: bib93 article-title: Systemic lupus erythematosus: perinatal outcomes in patients treated with and without hydroxychloroquine publication-title: Ochsner J – volume: 208 start-page: 64.e1-7 year: 2013 ident: bib107 article-title: Maternal autoantibody levels in congenital heart block and potential prophylaxis with antiinflammatory agents publication-title: Am J Obstet Gynecol – volume: 77 start-page: 531 year: 1995 end-page: 542 ident: bib36 article-title: Chloroquine inhibits stimulated platelets at the arachidonic acid pathway publication-title: Thromb Res – volume: 30 start-page: 1163 year: 2021 end-page: 1174 ident: bib87 article-title: Hydroxychloroquine prophylaxis for preeclampsia, hypertension and prematurity in pregnant patients with systemic lupus erythematosus: a meta-analysis publication-title: Lupus – volume: 19 start-page: 1665 year: 2010 end-page: 1673 ident: bib100 article-title: Pregnancy outcome in 396 pregnancies in patients with SLE in Saudi Arabia publication-title: Lupus – volume: 87 start-page: 518 year: 2002 end-page: 522 ident: bib37 article-title: Hydroxychloroquine reverses platelet activation induced by human IgG antiphospholipid antibodies publication-title: Thromb Haemost – volume: 48 start-page: 3207 year: 2003 end-page: 3211 ident: bib67 article-title: Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group publication-title: Arthritis Rheum – volume: 76 start-page: 919 year: 2024 end-page: 927 ident: bib84 article-title: Hydroxychloroquine in lupus pregnancy and risk of preeclampsia publication-title: Arthritis Rheumatol – year: 2024 ident: bib142 article-title: Hydroxychloroquine levels in pregnancy and materno-fetal outcomes in Systemic Lupus Erythematosus patients publication-title: Rheumatology (Oxford) – volume: 59 start-page: 12 year: 2021 end-page: 23 ident: bib75 article-title: Toxicity of chloroquine and hydroxychloroquine following therapeutic use or overdose publication-title: Clin Toxicol (Phila) – volume: 68 start-page: 766 year: 2013 end-page: 771 ident: bib17 article-title: Hydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheumatoid arthritis patients publication-title: Clinics (Sao Paulo) – volume: 11 year: 2024 ident: bib85 article-title: Effect of hydroxychloroquine on pregnancy outcome in patients with SLE: a systematic review and meta-analysis publication-title: Lupus Sci Med – volume: 115 start-page: 285 year: 2016 end-page: 290 ident: bib123 article-title: The efficacy of hydroxychloroquine in altering pregnancy outcome in women with antiphospholipid antibodies. Evidence and clinical judgment publication-title: Thromb Haemost – volume: 9 year: 2025 ident: bib41 article-title: A cell-based model to study mechanisms of endothelial-dependent thrombin generation in response to inflammation and its modulation by hydroxychloroquine publication-title: Res Pract Thromb Haemost – volume: 7 start-page: 174 year: 2008 end-page: 178 ident: bib114 article-title: Lessons from the "Euro-Phospholipid" project publication-title: Autoimmun Rev – volume: 15 start-page: 577 year: 2006 end-page: 583 ident: bib23 article-title: Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus publication-title: Lupus – volume: 77 start-page: 264 year: 2018 end-page: 269 ident: bib3 article-title: Influence of disease activity and medications on offspring birth weight, pre-eclampsia and preterm birth in systemic lupus erythematosus: a population-based study publication-title: Ann Rheum Dis – volume: 37 start-page: S297 year: 1994 ident: bib22 article-title: Arterial thrombotic events (TE) in SLE: the Baltimore Lupus Cohort study publication-title: Arthr. Rheum – volume: 64 start-page: 16 year: 2016 end-page: 20 ident: bib6 article-title: Reproductive health in systemic lupus erythematosus, an experience from government hospital in Western India publication-title: J Assoc Physicians India – volume: 20 start-page: 892 year: 2019 ident: bib116 article-title: The impact of autoantibodies on IVF treatment and outcome: a systematic review publication-title: Int J Mol Sci – volume: 30 start-page: 1435 year: 1987 end-page: 1436 ident: bib24 article-title: Does hydroxychloroquine sulfate prevent clot formation in systemic lupus erythematosus? publication-title: Arthritis Rheum – volume: 76 start-page: 1390 year: 2024 end-page: 1395 ident: bib90 article-title: Hydroxychloroquine and pre-eclampsia in a diverse cohort of women with systemic lupus erythematosus publication-title: Arthritis Care Res (Hoboken) – volume: 141 start-page: 122 year: 1963 end-page: 130 ident: bib48 article-title: Effects of hydroxychloroquine on the growth of mammalian cells in vitro publication-title: J Pharmacol Exp Ther – volume: 33 start-page: 267 year: 2007 end-page: 285 ident: bib102 article-title: Neonatal lupus syndromes publication-title: Rheum Dis Clin North Am – volume: 35 start-page: 1725 year: 2016 end-page: 1732 ident: bib4 article-title: Organ-specific systemic lupus erythematosus activity during pregnancy is associated with adverse pregnancy outcomes publication-title: Clin Rheumatol – volume: 206 start-page: 104 year: 2021 end-page: 110 ident: bib129 article-title: The impact of hydroxychloroquine on obstetric outcomes in refractory obstetric antiphospholipid syndrome publication-title: Thromb Res – volume: 75 start-page: 19 year: 1983 end-page: 24 ident: bib12 article-title: Immunosuppressive potential of antimalarials publication-title: Am J Med – volume: 8 start-page: 214 year: 1962 end-page: 221 ident: bib32 article-title: Desludging action of hydroxychloroquine in R.A publication-title: Acta Rheum Scand – volume: 76 start-page: 1606 year: 2024 end-page: 1616 ident: bib134 article-title: Therapeutic hydroxychloroquine blood levels are associated with fewer hospitalizations and possible reduction of health disparities in lupus publication-title: Arthritis Care Res (Hoboken) – volume: 126 start-page: 76 year: 2012 end-page: 82 ident: bib105 article-title: Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody-associated cardiac manifestations of neonatal lupus publication-title: Circulation – volume: 23 start-page: 319 year: 2003 end-page: 323 ident: bib78 article-title: Differential diagnosis of high serum creatine kinase levels in systemic lupus erythematosus publication-title: Rheumatol Int – volume: 60 start-page: 2317 year: 2021 end-page: 2326 ident: bib70 article-title: Fetal safety of chloroquine and hydroxychloroquine use during pregnancy: a nationwide cohort study publication-title: Rheumatology (Oxford) – volume: 38 start-page: 1080 year: 2020 end-page: 1087 ident: bib60 article-title: Perinatal exposure to conventional synthetic disease-modifying anti-rheumatic drugs in women with rheumatic disease and neonatal outcomes: a population-based study publication-title: Clin Exp Rheumatol – volume: 54 start-page: 3068 year: 2006 end-page: 3070 ident: bib9 article-title: Antimalarial agents: closing the gate on Toll-like receptors? publication-title: Arthritis Rheum – volume: 87 start-page: 50 year: 2019 end-page: 59 ident: bib46 article-title: Effects of hydroxychloroquine on the human placenta-Findings from in vitro experimental data and a systematic review publication-title: Reprod Toxicol – volume: 5 start-page: e501 year: 2023 end-page: e506 ident: bib72 article-title: Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseases publication-title: Lancet Rheumatol – volume: 28 start-page: 722 year: 2019 end-page: 730 ident: bib97 article-title: Hydroxychloroquine treatment during pregnancy in lupus patients is associated with lower risk of preeclampsia publication-title: Lupus – volume: 75 start-page: 1547 year: 2019 end-page: 1553 ident: bib144 article-title: Breast milk concentration of hydroxychloroquine in Chinese lactating women with connective tissue diseases publication-title: Eur J Clin Pharmacol – volume: 65 start-page: 17 year: 2017 end-page: 24 ident: bib40 article-title: Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndrome publication-title: Immunol Res – volume: 55 start-page: 486 year: 1996 end-page: 488 ident: bib69 article-title: Hydroxychloroquine and lupus pregnancy: review of a series of 36 cases publication-title: Ann Rheum Dis – volume: 76 start-page: 292 year: 2020 end-page: 302 ident: bib111 article-title: Hydroxychloroquine to prevent recurrent congenital heart block in fetuses of anti-SSA/Ro-positive mothers publication-title: J Am Coll Cardiol – volume: 168 start-page: 191 year: 2025 end-page: 199 ident: bib43 article-title: Effect of hydroxychloroquine on trophoblastic invasion in relation to autophagy mediated by ET-1 and ERK publication-title: Placenta – volume: 10 year: 2023 ident: bib136 article-title: Hydroxychloroquine daily dose, hydroxychloroquine blood levels and the risk of flares in patients with systemic lupus erythematosus publication-title: Lupus Sci Med – volume: 13 start-page: 29 year: 2006 end-page: 37 ident: bib117 article-title: Antiphospholipid antibodies and coagulation defects in women with implantation failure after IVF and recurrent miscarriage publication-title: Reprod Biomed Online – volume: 24 start-page: 1384 year: 2015 end-page: 1391 ident: bib62 article-title: Impact of hydroxychloroquine on preterm delivery and intrauterine growth restriction in pregnant women with systemic lupus erythematosus: a descriptive cohort study publication-title: Lupus – volume: 286 start-page: 30444 year: 2011 end-page: 30454 ident: bib103 article-title: A novel role of endothelin-1 in linking Toll-like receptor 7-mediated inflammation to fibrosis in congenital heart block publication-title: J Biol Chem – volume: 24 start-page: 55 year: 1997 end-page: 60 ident: bib13 article-title: Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-alpha, interleukin 6, and interferon-gamma production by peripheral blood mononuclear cells publication-title: J Rheumatol – volume: 54 start-page: 3640 year: 2006 end-page: 3647 ident: bib66 article-title: Hydroxychloroquine in lupus pregnancy publication-title: Arthritis Rheum – volume: 17 start-page: 1153 year: 2018 end-page: 1168 ident: bib130 article-title: HIBISCUS: hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome publication-title: Autoimmun Rev – volume: 38 start-page: 2211 year: 2019 end-page: 2217 ident: bib110 article-title: Causes of fetal third-degree atrioventricular block and use of hydroxychloroquine in pregnant women with Ro/La antibodies publication-title: Clin Rheumatol – volume: 205 start-page: 576.e7 year: 2011 ident: bib122 article-title: Hydroxychloroquine reduces binding of antiphospholipid antibodies to syncytiotrophoblasts and restores annexin A5 expression publication-title: Am J Obstet Gynecol – volume: 4 start-page: 48 year: 1984 end-page: 52 ident: bib33 article-title: Modification of transoperative changes in blood fluidity by hydroxychloroquine: a possible explanation for the drug's antithrombotic effect publication-title: Pharmatherapeutica – year: 2019 ident: bib139 article-title: Optimal hydroxychloroquine drug levels in pregnant women with systemic lupus erythematosus – volume: 54 start-page: 53 year: 2014 end-page: 69 ident: bib137 article-title: Pharmacometrics in pregnancy: an unmet need publication-title: Annu Rev Pharmacol Toxicol – volume: 76 start-page: 891 year: 2017 end-page: 897 ident: bib19 article-title: Hydroxychloroquine inhibits proinflammatory signalling pathways by targeting endosomal NADPH oxidase publication-title: Ann Rheum Dis – volume: 47 start-page: 570 year: 2021 end-page: 575 ident: bib98 article-title: Impact of hydroxychloroquine on the gestational outcomes of pregnant women with immune system problems that necessitate the use of the drug publication-title: J Obstet Gynaecol Res – volume: 39 start-page: 58 year: 2013 ident: 10.1016/j.ajog.2025.09.002_bib64 article-title: Pregnancy outcome following in utero exposure to hydroxychloroquine: a prospective comparative observational study publication-title: Reprod Toxicol doi: 10.1016/j.reprotox.2013.04.005 – volume: 126 start-page: 76 year: 2012 ident: 10.1016/j.ajog.2025.09.002_bib105 article-title: Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody-associated cardiac manifestations of neonatal lupus publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.111.089268 – volume: 87 start-page: 50 year: 2019 ident: 10.1016/j.ajog.2025.09.002_bib46 article-title: Effects of hydroxychloroquine on the human placenta-Findings from in vitro experimental data and a systematic review publication-title: Reprod Toxicol doi: 10.1016/j.reprotox.2019.05.056 – volume: 41 start-page: 924 year: 2002 ident: 10.1016/j.ajog.2025.09.002_bib27 article-title: A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome publication-title: Rheumatology (Oxford) doi: 10.1093/rheumatology/41.8.924 – volume: 35 start-page: 1725 year: 2016 ident: 10.1016/j.ajog.2025.09.002_bib4 article-title: Organ-specific systemic lupus erythematosus activity during pregnancy is associated with adverse pregnancy outcomes publication-title: Clin Rheumatol doi: 10.1007/s10067-016-3270-5 – volume: 76 start-page: 891 year: 2017 ident: 10.1016/j.ajog.2025.09.002_bib19 article-title: Hydroxychloroquine inhibits proinflammatory signalling pathways by targeting endosomal NADPH oxidase publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2016-210012 – volume: 54 start-page: 3640 year: 2006 ident: 10.1016/j.ajog.2025.09.002_bib66 article-title: Hydroxychloroquine in lupus pregnancy publication-title: Arthritis Rheum doi: 10.1002/art.22159 – volume: 62 start-page: 863 year: 2010 ident: 10.1016/j.ajog.2025.09.002_bib26 article-title: The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosus publication-title: Arthritis Rheum doi: 10.1002/art.27289 – volume: 24 start-page: 1384 year: 2015 ident: 10.1016/j.ajog.2025.09.002_bib62 article-title: Impact of hydroxychloroquine on preterm delivery and intrauterine growth restriction in pregnant women with systemic lupus erythematosus: a descriptive cohort study publication-title: Lupus doi: 10.1177/0961203315591027 – volume: 41 start-page: 196 year: 2012 ident: 10.1016/j.ajog.2025.09.002_bib65 article-title: Outcomes after anti-rheumatic drug use before and during pregnancy: a cohort study among 150,000 pregnant women and expectant fathers publication-title: Scand J Rheumatol doi: 10.3109/03009742.2011.626442 – volume: 41 start-page: 685 year: 2023 ident: 10.1016/j.ajog.2025.09.002_bib113 article-title: Anti-SSA/Ro positivity and congenital heart block: obstetric and foetal outcome in a cohort of anti-SSA/Ro positive pregnant patients with and without autoimmune diseases publication-title: Clin Exp Rheumatol – volume: 72 start-page: 461 year: 2020 ident: 10.1016/j.ajog.2025.09.002_bib50 article-title: 2020 American college of rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases publication-title: Arthritis Care Res (Hoboken) doi: 10.1002/acr.24130 – volume: 31 start-page: 14 year: 2023 ident: 10.1016/j.ajog.2025.09.002_bib92 article-title: Preeclampsia in women with lupus - influence of aspirin and hydroxychloroquine on pregnancy outcome publication-title: Pregnancy Hypertens doi: 10.1016/j.preghy.2022.11.006 – volume: 16 start-page: 155 year: 2020 ident: 10.1016/j.ajog.2025.09.002_bib8 article-title: Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology publication-title: Nat Rev Rheumatol doi: 10.1038/s41584-020-0372-x – volume: 44 start-page: 204 year: 2021 ident: 10.1016/j.ajog.2025.09.002_bib94 article-title: Low incidence of intrauterine growth restriction in pregnant patients with systemic lupus erythematosus taking hydroxychloroquine publication-title: Immunol Med doi: 10.1080/25785826.2020.1868652 – volume: 24 start-page: 147 year: 2015 ident: 10.1016/j.ajog.2025.09.002_bib101 article-title: Renal biopsy in the management of lupus nephritis during pregnancy publication-title: Lupus doi: 10.1177/0961203314551812 – volume: 55 start-page: 486 year: 1996 ident: 10.1016/j.ajog.2025.09.002_bib69 article-title: Hydroxychloroquine and lupus pregnancy: review of a series of 36 cases publication-title: Ann Rheum Dis doi: 10.1136/ard.55.7.486 – volume: 17 start-page: 215 year: 2021 ident: 10.1016/j.ajog.2025.09.002_bib147 article-title: Update of the Mexican College of rheumatology guidelines for the pharmacological treatment of rheumatoid arthritis, 2018 publication-title: Reumatol Clin (Engl Ed) doi: 10.1016/j.reuma.2019.04.002 – volume: 228 start-page: B41 year: 2023 ident: 10.1016/j.ajog.2025.09.002_bib53 article-title: Society for maternal-fetal medicine consult series #64: systemic lupus erythematosus in pregnancy publication-title: Am J Obstet Gynecol doi: 10.1016/j.ajog.2022.09.001 – volume: 73 start-page: 997 year: 2021 ident: 10.1016/j.ajog.2025.09.002_bib30 article-title: Association of higher hydroxychloroquine blood levels with reduced thrombosis risk in systemic lupus erythematosus publication-title: Arthritis Rheumatol doi: 10.1002/art.41621 – volume: 77 start-page: 531 year: 1995 ident: 10.1016/j.ajog.2025.09.002_bib36 article-title: Chloroquine inhibits stimulated platelets at the arachidonic acid pathway publication-title: Thromb Res doi: 10.1016/0049-3848(95)00028-3 – volume: 337 start-page: 154 year: 1997 ident: 10.1016/j.ajog.2025.09.002_bib118 article-title: Pregnancy loss in the antiphospholipid-antibody syndrome--a possible thrombogenic mechanism publication-title: N Engl J Med doi: 10.1056/NEJM199707173370303 – volume: 11 year: 2024 ident: 10.1016/j.ajog.2025.09.002_bib85 article-title: Effect of hydroxychloroquine on pregnancy outcome in patients with SLE: a systematic review and meta-analysis publication-title: Lupus Sci Med doi: 10.1136/lupus-2024-001239 – volume: 165 start-page: 1534 year: 2000 ident: 10.1016/j.ajog.2025.09.002_bib14 article-title: Chloroquine interferes with lipopolysaccharide-induced TNF-alpha gene expression by a nonlysosomotropic mechanism publication-title: J Immunol doi: 10.4049/jimmunol.165.3.1534 – volume: 85 start-page: 663 year: 2018 ident: 10.1016/j.ajog.2025.09.002_bib89 article-title: Hydroxychloroquine for the prevention of fetal growth restriction and prematurity in lupus pregnancy: a systematic review and meta-analysis publication-title: Joint Bone Spine doi: 10.1016/j.jbspin.2018.03.006 – volume: 5 start-page: e501 year: 2023 ident: 10.1016/j.ajog.2025.09.002_bib72 article-title: Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseases publication-title: Lancet Rheumatol doi: 10.1016/S2665-9913(23)00215-1 – volume: 74 start-page: 495 year: 1994 ident: 10.1016/j.ajog.2025.09.002_bib34 article-title: On the inhibitory effect of chloroquine on blood platelet aggregation publication-title: Thromb Res doi: 10.1016/0049-3848(94)90270-4 – volume: 76 start-page: 1390 year: 2024 ident: 10.1016/j.ajog.2025.09.002_bib90 article-title: Hydroxychloroquine and pre-eclampsia in a diverse cohort of women with systemic lupus erythematosus publication-title: Arthritis Care Res (Hoboken) doi: 10.1002/acr.25386 – volume: 20 start-page: 362 year: 2020 ident: 10.1016/j.ajog.2025.09.002_bib93 article-title: Systemic lupus erythematosus: perinatal outcomes in patients treated with and without hydroxychloroquine publication-title: Ochsner J doi: 10.31486/toj.20.0013 – volume: 213 start-page: S9.e1 issue: 4 Suppl year: 2015 ident: 10.1016/j.ajog.2025.09.002_bib18 article-title: Preeclampsia, biomarkers, syncytiotrophoblast stress, and placental capacity publication-title: Am J Obstet Gynecol doi: 10.1016/j.ajog.2015.08.003 – volume: 4 issue: Suppl 1 year: 2018 ident: 10.1016/j.ajog.2025.09.002_bib124 article-title: Antiphospholipid syndrome: state of the art on clinical practice guidelines publication-title: RMD Open doi: 10.1136/rmdopen-2018-000785 – volume: 48 start-page: 3207 year: 2003 ident: 10.1016/j.ajog.2025.09.002_bib67 article-title: Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group publication-title: Arthritis Rheum doi: 10.1002/art.11304 – volume: 87 start-page: 518 year: 2002 ident: 10.1016/j.ajog.2025.09.002_bib37 article-title: Hydroxychloroquine reverses platelet activation induced by human IgG antiphospholipid antibodies publication-title: Thromb Haemost doi: 10.1055/s-0037-1613033 – volume: 770 year: 2025 ident: 10.1016/j.ajog.2025.09.002_bib44 article-title: Hydroxychloroquine confers placental protection in antiphospholipid syndrome: mechanistic insights into autophagy regulation and trophoblast dysfunction publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2025.151994 – volume: 39 start-page: 1099 year: 2021 ident: 10.1016/j.ajog.2025.09.002_bib74 article-title: The safety profile of hydroxychloroquine: major cutaneous and extracutaneous adverse events publication-title: Clin Exp Rheumatol doi: 10.55563/clinexprheumatol/styx9u – volume: 126 year: 2024 ident: 10.1016/j.ajog.2025.09.002_bib135 article-title: The presumable effects of hydroxychloroquine and its metabolites in the treatment of systemic lupus erythematosus publication-title: Int Immunopharmacol doi: 10.1016/j.intimp.2023.111269 – volume: 47 start-page: 570 year: 2021 ident: 10.1016/j.ajog.2025.09.002_bib98 article-title: Impact of hydroxychloroquine on the gestational outcomes of pregnant women with immune system problems that necessitate the use of the drug publication-title: J Obstet Gynaecol Res doi: 10.1111/jog.14561 – volume: 62 start-page: e48 year: 2023 ident: 10.1016/j.ajog.2025.09.002_bib51 article-title: British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids publication-title: Rheumatology (Oxford) doi: 10.1093/rheumatology/keac551 – volume: 7 start-page: 174 year: 2008 ident: 10.1016/j.ajog.2025.09.002_bib114 article-title: Lessons from the "Euro-Phospholipid" project publication-title: Autoimmun Rev doi: 10.1016/j.autrev.2007.11.011 – volume: 69 start-page: 1827 year: 2010 ident: 10.1016/j.ajog.2025.09.002_bib106 article-title: Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine publication-title: Ann Rheum Dis doi: 10.1136/ard.2009.119263 – volume: 23 start-page: 319 year: 2003 ident: 10.1016/j.ajog.2025.09.002_bib78 article-title: Differential diagnosis of high serum creatine kinase levels in systemic lupus erythematosus publication-title: Rheumatol Int doi: 10.1007/s00296-003-0309-0 – volume: 214 start-page: 273.e1 year: 2016 ident: 10.1016/j.ajog.2025.09.002_bib126 article-title: The impact of hydroxychloroquine treatment on pregnancy outcome in women with antiphospholipid antibodies publication-title: Am J Obstet Gynecol doi: 10.1016/j.ajog.2015.09.078 – volume: 172 start-page: 1630 year: 1960 ident: 10.1016/j.ajog.2025.09.002_bib31 article-title: Use of antimalarial drugs as "desludging" agents in vascular disease processes publication-title: J Am Med Assoc doi: 10.1001/jama.1960.03020150054010 – volume: 46 start-page: 598 year: 2018 ident: 10.1016/j.ajog.2025.09.002_bib131 article-title: [Hydroxychloroquine to obtain pregnancy without adverse obstetrical events in primary antiphospholipid syndrome: French phase II multicenter randomized trial, HYDROSAPL] publication-title: Gynecol Obstet Fertil Senol – volume: 76 start-page: 1606 year: 2024 ident: 10.1016/j.ajog.2025.09.002_bib134 article-title: Therapeutic hydroxychloroquine blood levels are associated with fewer hospitalizations and possible reduction of health disparities in lupus publication-title: Arthritis Care Res (Hoboken) doi: 10.1002/acr.25422 – volume: 19 start-page: 460 year: 2010 ident: 10.1016/j.ajog.2025.09.002_bib120 article-title: The annexin A5-mediated pathogenic mechanism in the antiphospholipid syndrome: role in pregnancy losses and thrombosis publication-title: Lupus doi: 10.1177/0961203310361485 – volume: 36 start-page: E261 year: 2016 ident: 10.1016/j.ajog.2025.09.002_bib145 publication-title: Excretion of hydroxychloroquine in milk of lactating patients. Pharmacotherapy – volume: 108 start-page: 776 year: 2001 ident: 10.1016/j.ajog.2025.09.002_bib148 article-title: AoPCo. Transfer of drugs and other chemicals into human milk publication-title: Pediatrics doi: 10.1542/peds.108.3.776 – volume: 95 start-page: 3460 year: 2000 ident: 10.1016/j.ajog.2025.09.002_bib20 article-title: Hydroxychloroquine inhibits calcium signals in T cells: a new mechanism to explain its immunomodulatory properties publication-title: Blood doi: 10.1182/blood.V95.11.3460 – volume: 66 start-page: 444 year: 2014 ident: 10.1016/j.ajog.2025.09.002_bib63 article-title: Brief report: risk of adverse fetal outcomes associated with immunosuppressive medications for chronic immune-mediated diseases in pregnancy publication-title: Arthritis Rheumatol doi: 10.1002/art.38262 – volume: 286 start-page: 30444 year: 2011 ident: 10.1016/j.ajog.2025.09.002_bib103 article-title: A novel role of endothelin-1 in linking Toll-like receptor 7-mediated inflammation to fibrosis in congenital heart block publication-title: J Biol Chem doi: 10.1074/jbc.M111.263657 – volume: 141 start-page: 122 year: 1963 ident: 10.1016/j.ajog.2025.09.002_bib48 article-title: Effects of hydroxychloroquine on the growth of mammalian cells in vitro publication-title: J Pharmacol Exp Ther doi: 10.1016/S0022-3565(25)26585-5 – volume: 59 start-page: 12 year: 2021 ident: 10.1016/j.ajog.2025.09.002_bib75 article-title: Toxicity of chloroquine and hydroxychloroquine following therapeutic use or overdose publication-title: Clin Toxicol (Phila) doi: 10.1080/15563650.2020.1817479 – volume: 22 start-page: 263 year: 2014 ident: 10.1016/j.ajog.2025.09.002_bib104 article-title: Prevention and treatment in utero of autoimmune-associated congenital heart block publication-title: Cardiol Rev doi: 10.1097/CRD.0000000000000026 – volume: 76 start-page: 526 year: 2024 ident: 10.1016/j.ajog.2025.09.002_bib1 article-title: Pregnancy outcomes in a diverse US lupus cohort publication-title: Arthritis Care Res (Hoboken) doi: 10.1002/acr.25279 – volume: 50 start-page: 143 year: 1990 ident: 10.1016/j.ajog.2025.09.002_bib35 article-title: [Antiaggregation action of chloroquine] publication-title: Med Trop (Mars) – volume: 32 start-page: 547 year: 1973 ident: 10.1016/j.ajog.2025.09.002_bib49 article-title: Action of chloroquine phosphate in rheumatoid arthritis. II. Chromosome damaging effect publication-title: Ann Rheum Dis doi: 10.1136/ard.32.6.547 – volume: 208 start-page: 64.e1-7 year: 2013 ident: 10.1016/j.ajog.2025.09.002_bib107 article-title: Maternal autoantibody levels in congenital heart block and potential prophylaxis with antiinflammatory agents publication-title: Am J Obstet Gynecol doi: 10.1016/j.ajog.2012.09.020 – volume: 37 start-page: 873 year: 2020 ident: 10.1016/j.ajog.2025.09.002_bib96 article-title: Does hydroxychloroquine protect against preeclampsia and preterm delivery in systemic lupus erythematosus pregnancies? publication-title: Am J Perinatol doi: 10.1055/s-0039-3402752 – year: 2019 ident: 10.1016/j.ajog.2025.09.002_bib139 – volume: 68 start-page: 238 year: 2009 ident: 10.1016/j.ajog.2025.09.002_bib29 article-title: Risk and protective factors for thrombosis in systemic lupus erythematosus: results from a large, multi-ethnic cohort publication-title: Ann Rheum Dis doi: 10.1136/ard.2008.093013 – volume: 159 start-page: 320 year: 2020 ident: 10.1016/j.ajog.2025.09.002_bib73 article-title: AGA institute rapid review of the gastrointestinal and liver manifestations of COVID-19, meta-analysis of international data, and recommendations for the consultative management of patients with COVID-19 publication-title: Gastroenterology doi: 10.1053/j.gastro.2020.05.001 – volume: 206 start-page: 104 year: 2021 ident: 10.1016/j.ajog.2025.09.002_bib129 article-title: The impact of hydroxychloroquine on obstetric outcomes in refractory obstetric antiphospholipid syndrome publication-title: Thromb Res doi: 10.1016/j.thromres.2021.08.004 – volume: 4 start-page: 48 year: 1984 ident: 10.1016/j.ajog.2025.09.002_bib33 article-title: Modification of transoperative changes in blood fluidity by hydroxychloroquine: a possible explanation for the drug's antithrombotic effect publication-title: Pharmatherapeutica – volume: 56 start-page: 1552 year: 2017 ident: 10.1016/j.ajog.2025.09.002_bib109 article-title: Prenatal exposure to antimalarials decreases the risk of cardiac but not non-cardiac neonatal lupus: a single-centre cohort study publication-title: Rheumatology (Oxford) doi: 10.1093/rheumatology/kex191 – volume: 61 start-page: 29 year: 2009 ident: 10.1016/j.ajog.2025.09.002_bib25 article-title: Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies publication-title: Arthritis Rheum doi: 10.1002/art.24232 – volume: 133 start-page: e287 year: 2019 ident: 10.1016/j.ajog.2025.09.002_bib54 article-title: ACOG Committee Opinion No. 776: immune modulating therapies in pregnancy and lactation publication-title: Obstet Gynecol doi: 10.1097/AOG.0000000000003176 – volume: 10 year: 2023 ident: 10.1016/j.ajog.2025.09.002_bib136 article-title: Hydroxychloroquine daily dose, hydroxychloroquine blood levels and the risk of flares in patients with systemic lupus erythematosus publication-title: Lupus Sci Med doi: 10.1136/lupus-2022-000841 – volume: 9 year: 2022 ident: 10.1016/j.ajog.2025.09.002_bib7 article-title: Hydroxychloroquine in the pregnancies of women with lupus: a meta-analysis of individual participant data publication-title: Lupus Sci Med doi: 10.1136/lupus-2021-000651 – volume: 12 year: 2021 ident: 10.1016/j.ajog.2025.09.002_bib71 article-title: Chloroquine and hydroxychloroquine use during pregnancy and the risk of adverse pregnancy outcomes using real-world evidence publication-title: Front Pharmacol doi: 10.3389/fphar.2021.722511 – volume: 24 start-page: 55 year: 1997 ident: 10.1016/j.ajog.2025.09.002_bib13 article-title: Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-alpha, interleukin 6, and interferon-gamma production by peripheral blood mononuclear cells publication-title: J Rheumatol – volume: 31 start-page: 238 year: 2022 ident: 10.1016/j.ajog.2025.09.002_bib28 article-title: Efficacy of hydroxychloroquine in the prevention of thromboembolic events: a systematic review and meta-analysis publication-title: Lupus doi: 10.1177/09612033221074192 – volume: 42 start-page: 1223 year: 2023 ident: 10.1016/j.ajog.2025.09.002_bib86 article-title: Hydroxychloroquine significantly decreases the risk of preeclampsia in pregnant women with autoimmune disorders: a systematic review and meta-analysis publication-title: Clin Rheumatol doi: 10.1007/s10067-022-06496-2 – volume: 46 start-page: 57 year: 2019 ident: 10.1016/j.ajog.2025.09.002_bib138 article-title: Hydroxychloroquine levels throughout pregnancies complicated by rheumatic disease: implications for maternal and neonatal outcomes publication-title: J Rheumatol doi: 10.3899/jrheum.180158 – volume: 54 start-page: 53 year: 2014 ident: 10.1016/j.ajog.2025.09.002_bib137 article-title: Pharmacometrics in pregnancy: an unmet need publication-title: Annu Rev Pharmacol Toxicol doi: 10.1146/annurev-pharmtox-011613-140009 – volume: 76 start-page: 476 year: 2017 ident: 10.1016/j.ajog.2025.09.002_bib82 article-title: EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2016-209770 – volume: 224 start-page: 290.e1 year: 2021 ident: 10.1016/j.ajog.2025.09.002_bib59 article-title: Hydroxychloroquine early in pregnancy and risk of birth defects publication-title: Am J Obstet Gynecol doi: 10.1016/j.ajog.2020.09.007 – volume: 57 start-page: 463 year: 2023 ident: 10.1016/j.ajog.2025.09.002_bib76 article-title: Systematic review of psychiatric adverse effects induced by chloroquine and hydroxychloroquine: case reports and population studies publication-title: Ann Pharmacother doi: 10.1177/10600280221113572 – volume: 118 start-page: 639 year: 2018 ident: 10.1016/j.ajog.2025.09.002_bib128 article-title: Effect of additional treatments combined with conventional therapies in pregnant patients with high-risk antiphospholipid syndrome: a multicentre study publication-title: Thromb Haemost – volume: 53 start-page: i55 year: 2014 ident: 10.1016/j.ajog.2025.09.002_bib143 article-title: Longterm outcomes of children born to mothers with SLE exposed to hydroxychloroquine in pregnancy publication-title: Rheumatology doi: 10.1093/rheumatology/keu095.004 – volume: 42 start-page: 705 year: 2020 ident: 10.1016/j.ajog.2025.09.002_bib95 article-title: New benefits of hydroxychloroquine in pregnant women with systemic lupus erythematosus: a retrospective study in a tertiary centre publication-title: Rev Bras Ginecol Obstet doi: 10.1055/s-0040-1715140 – volume: 39 start-page: 1014 year: 2000 ident: 10.1016/j.ajog.2025.09.002_bib5 article-title: Outcome of lupus pregnancy: a controlled study publication-title: Rheumatology (Oxford) doi: 10.1093/rheumatology/39.9.1014 – volume: 75 start-page: 1547 year: 2019 ident: 10.1016/j.ajog.2025.09.002_bib144 article-title: Breast milk concentration of hydroxychloroquine in Chinese lactating women with connective tissue diseases publication-title: Eur J Clin Pharmacol doi: 10.1007/s00228-019-02723-z – year: 2024 ident: 10.1016/j.ajog.2025.09.002_bib142 article-title: Hydroxychloroquine levels in pregnancy and materno-fetal outcomes in Systemic Lupus Erythematosus patients publication-title: Rheumatology (Oxford) – volume: 76 start-page: 292 year: 2020 ident: 10.1016/j.ajog.2025.09.002_bib111 article-title: Hydroxychloroquine to prevent recurrent congenital heart block in fetuses of anti-SSA/Ro-positive mothers publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2020.05.045 – volume: 120 start-page: 1514 year: 2012 ident: 10.1016/j.ajog.2025.09.002_bib133 article-title: Practice bulletin No. 132: antiphospholipid syndrome publication-title: Obstet Gynecol doi: 10.1097/01.AOG.0000423816.39542.0f – volume: 8 start-page: 214 year: 1962 ident: 10.1016/j.ajog.2025.09.002_bib32 article-title: Desludging action of hydroxychloroquine in R.A publication-title: Acta Rheum Scand doi: 10.3109/03009746209165073 – volume: 74 start-page: 711 year: 2022 ident: 10.1016/j.ajog.2025.09.002_bib57 article-title: Birth outcomes in women who have taken hydroxycholoroquine during pregnancy: a prospective cohort study publication-title: Arthritis Rheumatol doi: 10.1002/art.42015 – volume: 11 start-page: 675 year: 2022 ident: 10.1016/j.ajog.2025.09.002_bib119 article-title: Pathogenesis, diagnosis and management of obstetric antiphospholipid syndrome: a comprehensive review publication-title: J Clin Med doi: 10.3390/jcm11030675 – volume: 68 start-page: 766 year: 2013 ident: 10.1016/j.ajog.2025.09.002_bib17 article-title: Hydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheumatoid arthritis patients publication-title: Clinics (Sao Paulo) doi: 10.6061/clinics/2013(06)07 – volume: 24 start-page: 210 year: 2015 ident: 10.1016/j.ajog.2025.09.002_bib99 article-title: Hydroxychloroquine and pregnancy on lupus flares in Korean patients with systemic lupus erythematosus publication-title: Lupus doi: 10.1177/0961203314555352 – volume: 20 start-page: 892 year: 2019 ident: 10.1016/j.ajog.2025.09.002_bib116 article-title: The impact of autoantibodies on IVF treatment and outcome: a systematic review publication-title: Int J Mol Sci doi: 10.3390/ijms20040892 – volume: 171 start-page: 164 year: 2019 ident: 10.1016/j.ajog.2025.09.002_bib2 article-title: Trends in maternal and fetal outcomes among pregnant women with systemic lupus erythematosus in the United States: a cross-sectional analysis publication-title: Ann Intern Med doi: 10.7326/M19-0120 – volume: 62 start-page: 1124 year: 2023 ident: 10.1016/j.ajog.2025.09.002_bib56 article-title: Outcomes of children born to mothers with systemic lupus erythematosus exposed to hydroxychloroquine or azathioprine publication-title: Rheumatology (Oxford) doi: 10.1093/rheumatology/keac372 – volume: 205 start-page: 576.e7 year: 2011 ident: 10.1016/j.ajog.2025.09.002_bib122 article-title: Hydroxychloroquine reduces binding of antiphospholipid antibodies to syncytiotrophoblasts and restores annexin A5 expression publication-title: Am J Obstet Gynecol doi: 10.1016/j.ajog.2011.06.064 – volume: 9 year: 2025 ident: 10.1016/j.ajog.2025.09.002_bib41 article-title: A cell-based model to study mechanisms of endothelial-dependent thrombin generation in response to inflammation and its modulation by hydroxychloroquine publication-title: Res Pract Thromb Haemost doi: 10.1016/j.rpth.2024.102665 – volume: 130 start-page: 1395 year: 2017 ident: 10.1016/j.ajog.2025.09.002_bib127 article-title: Efficacy of different treatment regimens for antiphospholipid syndrome-related recurrent spontaneous abortion publication-title: Chin Med J (Engl) doi: 10.4103/0366-6999.207471 – volume: 43 start-page: 562 year: 2017 ident: 10.1016/j.ajog.2025.09.002_bib132 publication-title: Semin Thromb Hemost doi: 10.1055/s-0037-1603359 – volume: 35 start-page: 133 year: 1996 ident: 10.1016/j.ajog.2025.09.002_bib80 article-title: Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies publication-title: Br J Rheumatol doi: 10.1093/rheumatology/35.2.133 – volume: 9 start-page: 513 year: 1987 ident: 10.1016/j.ajog.2025.09.002_bib10 article-title: Effect of antimalarial drugs on stimulation and interleukin 2 production of human lymphocytes publication-title: Int J Immunopharmacol doi: 10.1016/0192-0561(87)90027-0 – volume: 10 start-page: 401 year: 2001 ident: 10.1016/j.ajog.2025.09.002_bib68 article-title: Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study publication-title: Lupus doi: 10.1191/096120301678646137 – volume: 15 start-page: 577 year: 2006 ident: 10.1016/j.ajog.2025.09.002_bib23 article-title: Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus publication-title: Lupus doi: 10.1177/0961203306071872 – volume: 30 start-page: 1163 year: 2021 ident: 10.1016/j.ajog.2025.09.002_bib87 article-title: Hydroxychloroquine prophylaxis for preeclampsia, hypertension and prematurity in pregnant patients with systemic lupus erythematosus: a meta-analysis publication-title: Lupus doi: 10.1177/09612033211007199 – volume: 13 start-page: 29 year: 2006 ident: 10.1016/j.ajog.2025.09.002_bib117 article-title: Antiphospholipid antibodies and coagulation defects in women with implantation failure after IVF and recurrent miscarriage publication-title: Reprod Biomed Online doi: 10.1016/S1472-6483(10)62013-5 – volume: 38 start-page: 1080 year: 2020 ident: 10.1016/j.ajog.2025.09.002_bib60 article-title: Perinatal exposure to conventional synthetic disease-modifying anti-rheumatic drugs in women with rheumatic disease and neonatal outcomes: a population-based study publication-title: Clin Exp Rheumatol – volume: 58 start-page: 525 year: 2019 ident: 10.1016/j.ajog.2025.09.002_bib140 article-title: Pharmacokinetics of hydroxychloroquine in pregnancies with rheumatic diseases publication-title: Clin Pharmacokinet doi: 10.1007/s40262-018-0712-z – volume: 60 start-page: 2317 year: 2021 ident: 10.1016/j.ajog.2025.09.002_bib70 article-title: Fetal safety of chloroquine and hydroxychloroquine use during pregnancy: a nationwide cohort study publication-title: Rheumatology (Oxford) doi: 10.1093/rheumatology/keaa592 – volume: 65 start-page: 487 year: 2017 ident: 10.1016/j.ajog.2025.09.002_bib108 article-title: Obstetric and perinatal outcome in anti-Ro/SSA-positive pregnant women: a prospective cohort study publication-title: Immunol Res doi: 10.1007/s12026-016-8888-5 – volume: 37 start-page: S297 year: 1994 ident: 10.1016/j.ajog.2025.09.002_bib22 article-title: Arterial thrombotic events (TE) in SLE: the Baltimore Lupus Cohort study publication-title: Arthr. Rheum – volume: 17 year: 2022 ident: 10.1016/j.ajog.2025.09.002_bib42 article-title: Hydroxychloroquine reduces soluble Flt-1 secretion from human cytotrophoblast, but does not mitigate markers of endothelial dysfunction in vitro publication-title: PLoS One doi: 10.1371/journal.pone.0271560 – volume: 40 start-page: 2459 year: 2022 ident: 10.1016/j.ajog.2025.09.002_bib45 article-title: Hydroxychloroquine reduces hypertension and soluble fms-like kinase-1 in a Nω-nitro-l-arginine methyl ester-induced preeclampsia rat model publication-title: J Hypertens doi: 10.1097/HJH.0000000000003279 – volume: 38 start-page: 2211 year: 2019 ident: 10.1016/j.ajog.2025.09.002_bib110 article-title: Causes of fetal third-degree atrioventricular block and use of hydroxychloroquine in pregnant women with Ro/La antibodies publication-title: Clin Rheumatol doi: 10.1007/s10067-019-04556-8 – volume: 113 start-page: 1245 year: 2021 ident: 10.1016/j.ajog.2025.09.002_bib58 article-title: Maternal exposure to hydroxychloroquine and birth defects publication-title: Birth Defects Res doi: 10.1002/bdr2.1943 – volume: 303 start-page: 435 year: 2021 ident: 10.1016/j.ajog.2025.09.002_bib88 article-title: Effect of hydroxychloroquine on preeclampsia in lupus pregnancies: a propensity score-matched analysis and meta-analysis publication-title: Arch Gynecol Obstet doi: 10.1007/s00404-020-05762-5 – volume: 19 start-page: 1665 year: 2010 ident: 10.1016/j.ajog.2025.09.002_bib100 article-title: Pregnancy outcome in 396 pregnancies in patients with SLE in Saudi Arabia publication-title: Lupus doi: 10.1177/0961203310378669 – volume: 75 start-page: 19 year: 1983 ident: 10.1016/j.ajog.2025.09.002_bib12 article-title: Immunosuppressive potential of antimalarials publication-title: Am J Med doi: 10.1016/0002-9343(83)91266-4 – volume: 64 start-page: 16 year: 2016 ident: 10.1016/j.ajog.2025.09.002_bib6 article-title: Reproductive health in systemic lupus erythematosus, an experience from government hospital in Western India publication-title: J Assoc Physicians India – volume: 71 start-page: 547 year: 2012 ident: 10.1016/j.ajog.2025.09.002_bib21 article-title: SAT0222 hydroxychloroquine reduces thrombosis (both arterial and venous) in systemic lupus erythematosus, particularly in antiphospholipid positive patients publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2012-eular.3169 – volume: 21 start-page: 830 year: 2012 ident: 10.1016/j.ajog.2025.09.002_bib15 article-title: Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA (LXXV), a multiethnic US cohort publication-title: Lupus doi: 10.1177/0961203312437270 – volume: 112 start-page: 1687 year: 2008 ident: 10.1016/j.ajog.2025.09.002_bib38 article-title: Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-beta2-glycoprotein I complexes to phospholipid bilayers publication-title: Blood doi: 10.1182/blood-2008-03-144204 – volume: 115 start-page: 285 year: 2016 ident: 10.1016/j.ajog.2025.09.002_bib123 article-title: The efficacy of hydroxychloroquine in altering pregnancy outcome in women with antiphospholipid antibodies. Evidence and clinical judgment publication-title: Thromb Haemost doi: 10.1160/th15-06-0491 – volume: 9 year: 2022 ident: 10.1016/j.ajog.2025.09.002_bib141 article-title: Hydroxychloroquine PK and exposure-response in pregnancies with lupus: the importance of adherence for neonatal outcomes publication-title: Lupus Sci Med doi: 10.1136/lupus-2021-000602 – volume: 64 start-page: 117 year: 2025 ident: 10.1016/j.ajog.2025.09.002_bib55 article-title: Hydroxychloroquine in lupus or rheumatoid arthritis pregnancy and risk of major congenital malformations: a population-based cohort study publication-title: Rheumatology (Oxford) doi: 10.1093/rheumatology/keae168 – volume: 2017 year: 2017 ident: 10.1016/j.ajog.2025.09.002_bib61 article-title: Hydroxychloroquine use in lupus patients during pregnancy is associated with longer pregnancy duration in preterm births publication-title: J Immunol Res doi: 10.1155/2017/2810202 – year: 2025 ident: 10.1016/j.ajog.2025.09.002_bib83 article-title: Exposure to hydroxychloroquine in early pregnancy and incidence of pre-eclampsia and pre-term delivery in patients with systemic lupus erythematosus in Sweden: a nationwide population-based cohort study publication-title: Lancet Rheumatol doi: 10.1016/S2665-9913(25)00076-1 – volume: 14 start-page: 498 year: 2015 ident: 10.1016/j.ajog.2025.09.002_bib125 article-title: The efficacy of hydroxychloroquine for obstetrical outcome in anti-phospholipid syndrome: data from a European multicenter retrospective study publication-title: Autoimmun Rev doi: 10.1016/j.autrev.2015.01.012 – volume: 65 start-page: 17 year: 2017 ident: 10.1016/j.ajog.2025.09.002_bib40 article-title: Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndrome publication-title: Immunol Res doi: 10.1007/s12026-016-8812-z – volume: 54 start-page: 3068 year: 2006 ident: 10.1016/j.ajog.2025.09.002_bib9 article-title: Antimalarial agents: closing the gate on Toll-like receptors? publication-title: Arthritis Rheum doi: 10.1002/art.22157 – volume: 31 start-page: 77 year: 2022 ident: 10.1016/j.ajog.2025.09.002_bib112 article-title: Prenatal predisposing factors associated with neonatal lupus erythematosus publication-title: Lupus doi: 10.1177/09612033211066455 – volume: 123 start-page: 1386 year: 2016 ident: 10.1016/j.ajog.2025.09.002_bib77 article-title: Recommendations on screening for chloroquine and hydroxychloroquine Retinopathy (2016 revision) publication-title: Ophthalmology doi: 10.1016/j.ophtha.2016.01.058 – volume: 8 start-page: 81 year: 2021 ident: 10.1016/j.ajog.2025.09.002_bib115 article-title: Antiphospholipid antibodies in inflammatory and autoimmune rheumatic and musculoskeletal diseases beyond lupus: a systematic review of the available evidence publication-title: Rheumatol Ther doi: 10.1007/s40744-020-00273-w – volume: 77 start-page: 264 year: 2018 ident: 10.1016/j.ajog.2025.09.002_bib3 article-title: Influence of disease activity and medications on offspring birth weight, pre-eclampsia and preterm birth in systemic lupus erythematosus: a population-based study publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2017-211641 – volume: 63 start-page: 1515 year: 2020 ident: 10.1016/j.ajog.2025.09.002_bib16 article-title: Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19 publication-title: Sci China Life Sci doi: 10.1007/s11427-020-1732-2 – volume: 12 start-page: 910 year: 2014 ident: 10.1016/j.ajog.2025.09.002_bib121 article-title: Hydroxychloroquine restores trophoblast fusion affected by antiphospholipid antibodies publication-title: J Thromb Haemost doi: 10.1111/jth.12570 – volume: 39 start-page: 1483 year: 2019 ident: 10.1016/j.ajog.2025.09.002_bib146 article-title: Kuwait association of rheumatology 2018 treatment recommendations for patients with rheumatoid arthritis publication-title: Rheumatol Int doi: 10.1007/s00296-019-04372-y – volume: 95 start-page: E194 year: 2020 ident: 10.1016/j.ajog.2025.09.002_bib79 article-title: Glucose-6-phosphate dehydrogenase deficiency-associated hemolysis and methemoglobinemia in a COVID-19 patient treated with chloroquine publication-title: Am J Hematol doi: 10.1002/ajh.25862 – volume: 84 start-page: 910 year: 2025 ident: 10.1016/j.ajog.2025.09.002_bib52 article-title: EULAR recommendations for use of antirheumatic drugs in reproduction, pregnancy, and lactation: 2024 update publication-title: Ann Rheum Dis doi: 10.1016/j.ard.2025.02.023 – volume: 2 start-page: S9 issue: Suppl 1 year: 1993 ident: 10.1016/j.ajog.2025.09.002_bib11 article-title: Mechanism of action of antimalarial drugs: inhibition of antigen processing and presentation publication-title: Lupus doi: 10.1177/0961203393002001031 – volume: 168 start-page: 191 year: 2025 ident: 10.1016/j.ajog.2025.09.002_bib43 article-title: Effect of hydroxychloroquine on trophoblastic invasion in relation to autophagy mediated by ET-1 and ERK publication-title: Placenta doi: 10.1016/j.placenta.2025.06.013 – volume: 163 start-page: 153 year: 2015 ident: 10.1016/j.ajog.2025.09.002_bib81 article-title: Predictors of pregnancy outcomes in patients with lupus: a cohort study publication-title: Ann Intern Med doi: 10.7326/M14-2235 – volume: 76 start-page: 919 year: 2024 ident: 10.1016/j.ajog.2025.09.002_bib84 article-title: Hydroxychloroquine in lupus pregnancy and risk of preeclampsia publication-title: Arthritis Rheumatol doi: 10.1002/art.42793 – volume: 30 start-page: 1435 year: 1987 ident: 10.1016/j.ajog.2025.09.002_bib24 article-title: Does hydroxychloroquine sulfate prevent clot formation in systemic lupus erythematosus? publication-title: Arthritis Rheum doi: 10.1002/art.1780301219 – volume: 12 start-page: 485 year: 2023 ident: 10.1016/j.ajog.2025.09.002_bib91 article-title: Effect of hydroxychloroquine on lupus activity, preeclampsia and intrauterine growth restriction in pregnant women with systemic lupus erythematosus and/or antiphospholipid syndrome: a systematic review and meta-analysis publication-title: J Clin Med doi: 10.3390/jcm12020485 – volume: 33 start-page: 267 year: 2007 ident: 10.1016/j.ajog.2025.09.002_bib102 article-title: Neonatal lupus syndromes publication-title: Rheum Dis Clin North Am doi: 10.1016/j.rdc.2007.02.005 – volume: 46 start-page: 1123 year: 2002 ident: 10.1016/j.ajog.2025.09.002_bib47 article-title: Evidence of transplacental passage of hydroxychloroquine in humans publication-title: Arthritis Rheum doi: 10.1002/art.10150 – volume: 28 start-page: 722 year: 2019 ident: 10.1016/j.ajog.2025.09.002_bib97 article-title: Hydroxychloroquine treatment during pregnancy in lupus patients is associated with lower risk of preeclampsia publication-title: Lupus doi: 10.1177/0961203319843343 – volume: 17 start-page: 1153 year: 2018 ident: 10.1016/j.ajog.2025.09.002_bib130 article-title: HIBISCUS: hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome publication-title: Autoimmun Rev doi: 10.1016/j.autrev.2018.05.012 – volume: 40 start-page: 30 year: 2013 ident: 10.1016/j.ajog.2025.09.002_bib39 article-title: Hydroxychloroquine use is associated with lower odds of persistently positive antiphospholipid antibodies and/or lupus anticoagulant in systemic lupus erythematosus publication-title: J Rheumatol doi: 10.3899/jrheum.120157 |
| SSID | ssj0002292 |
| Score | 2.4840453 |
| SecondaryResourceType | review_article online_first |
| Snippet | Pregnancies in patients with systemic lupus erythematosus (SLE) and those positive for anti-SSA/SSB or antiphospholipid antibodies carry a heightened risk of... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Publisher |
| SubjectTerms | adverse pregnancy outcomes antiphospholipid syndrome autoimmune rheumatic diseases congenital malformations hydroxychloroquine Obstetrics and Gynecology SSA/SSB positive systemic lupus erythematosus teratogenicity |
| Title | Hydroxychloroquine in systemic lupus erythematosus, anti-SSA/SSB, and antiphospholipid antibody-positive pregnancies |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0002937825006532 https://www.clinicalkey.es/playcontent/1-s2.0-S0002937825006532 https://dx.doi.org/10.1016/j.ajog.2025.09.002 https://www.ncbi.nlm.nih.gov/pubmed/40930382 https://www.proquest.com/docview/3248678566 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals 2021 customDbUrl: eissn: 1097-6868 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002292 issn: 0002-9378 databaseCode: AIEXJ dateStart: 20160801 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLbKhhAviOsolylIvJWU2Enq5LFMnQbSJkQHVLxYseN0qUpSNU21_gV-NcdxnLbrxk2iUqPGjp3G_nJuPucYodeSJKDeEN9OgP7bnsuxHeEETjGmAsc94Tu82myCnp0Fo1H4sdX6YWJhllOaZcHlZTj7r1MNZTDZKnT2L6a76RQK4DdMOhxh2uH4RxN_soqVa4q4AE0cqH6q04LojM2p6EzLWVl05Hyl07XmRVloD85Fag-HfbWyOnxnfDpV6ewiL-A7TWepLuB5vLK1s9dShVnJsd7it9gUdJuVoI3UFDmH_6B2BNB5ocerTIotq_4QuFVl5vkmVUxX57jb1OTf683cBpVB5qip-aRqKnvvl3SpqNW66jSaxxqRX2VWJ9GtDRwAG7VcE6ytbibyZssxtKLkIFoF17IBbZGYdKNJPu6qPqtctg5ZM73GFXGoelIdgSyo8vQCO98n1A-BQu733w9GHxq-TkhIjDKlGtQhWNpb8OqdbhJzblJjKnHm_D66V-shVl_j5wFqyewhunNae1o8QotdGFlpZhkYWRWMrC0YvbEMiN4ChNRZbF0FkLUDIGsDQI_R5-PB-dGJXe_QYQvXdRZ26NOY-LLnJ47LhcBRzEnkxBhLIkTociojrBLw-UkIakTEIw8TTjlc5iXSSyL3CdrL8kw-RZZMlOpBw0gIzyMJiM0Jp4KrfJgefHpt1DEDymY6EQszHooTpoafqeFnTshg-NvINWPOTIgxMEUGAPllK3pdK1nUr0rBMCsIc9gOaNrIb1rWoqsWSX97x1cGEAzoulqsizKZlwUDRScAQRK0rTY60EhpnttzQpA8A_Lsn57yObq7fs1eoL3FvJQv0W2xXKTF_BDdoqPgsMb-T4_p12k |
| linkProvider | Elsevier |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hydroxychloroquine+in+systemic+lupus+erythematosus%2C+anti-SSA%2FSSB%2C+and+antiphospholipid+antibody-positive+pregnancies&rft.jtitle=American+journal+of+obstetrics+and+gynecology&rft.au=Saleh%2C+Zeinab+F.&rft.au=Somers%2C+Emily+C.&rft.au=Romero%2C+Vivian+C.&rft.au=Marder%2C+Wendy&rft.date=2025-09-08&rft.pub=Elsevier+Inc&rft.issn=0002-9378&rft_id=info:doi/10.1016%2Fj.ajog.2025.09.002&rft.externalDocID=S0002937825006532 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0002-9378&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0002-9378&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0002-9378&client=summon |